Notas

 

 

 

 

 

Prólogo

 

[1]. Monte, T., Pritikin, I., Pritikin: The Man Who Healed America’s Heart, Rodale Press, Emmaus, PA, 1988.

[2]. Gould, K. L., Ornish, D., Scherwitz, L., et al., «Changes in myocardial perfusion abnormalities by positron emission tomography after long-term, intense risk factor modification», en JAMA, 274, 1995, pp. 894–901.

[3]. Ornish, D., Scherwitz, L., Billings, J., et al., «Intensive lifestyle changes for reversal of coronary heart disease. Five-year follow-up of the Lifestyle Heart Trial», en JAMA, 280, 1998, pp. 2001–2007.

[4]. Ornish, D. M., Scherwitz, L. W., Doody, R. S., et al., «Effects of stress management training and dietary changes in treating ischemic heart disease», en JAMA, 249, 1983, pp. 54–59.

[5]. Ornish, D., «Intensive lifestyle changes and health reform», en Lancet Oncol., 10(7), 2009, pp. 638–639.

[6]. Adams, K. M., Kohlmeier, M., Zeisel, S. H., «Nutrition education in U.S. medical schools: latest update of a national survey», en Acad Med., 85(9), 2010, pp. 1537–1542.

[7]. Jamal, A., Dube, S. R., Malarcher, A. M., Shaw, L., Engstrom, M. C., «Tobacco use screening and counseling during physician office visits among adults, National Ambulatory Medical Care Survey and National Health Interview Survey, United States, 2005–2009», en MMWR Morb Mortal Wkly Rep., 61, 2012, Sup., pp. 38–45.

 

 

Introducción

 

[1]. Berzlanovich, A. M., Keil, W., Waldhoer, T., Sim, E., Fasching, P., Fazeny-Dörner, B., «Do centenarians die healthy? An autopsy study», en J Gerontol A Biol Sci Med Sci., 60(7), 2005, pp. 862–865.

[2]. Kohn, R. R., «Cause of death in very old people», en JAMA, 247(20), 1982, pp. 2793–2797.

[3]. Berzlanovich, A. M., Keil, W., Waldhoer, T., Sim, E., Fasching, P., Fazeny-Dörner, B., «Do centenarians die healthy? An autopsy study», en J Gerontol A Biol Sci Med Sci., 60(7), 2005, pp. 862–865.

[4]. Lenders, C., Gorman, K., Milch, H., et al., «A novel nutrition medicine education model: the Boston University experience», en Adv Nutr., 4(1), 2013, pp. 1–7.

[5]. Murray, C. J., Atkinson, C., Bhalla, K., et al., «The state of US health, 1990-2010: burden of diseases, injuries, and risk factors», en JAMA, 310(6), 2013, pp. 591–608.

[6]. Kris-Etherton, P. M., Akabas, S. R., Bales, C. W., et al., «The need to advance nutrition education in the training of health care professionals and recommended research to evaluate implementation and effectiveness», en Am J Clin Nutr., 99(5 Sup.), 2014, pp. 1153S-1566S.

[7]. Swift, C. S., «Nutrition trends: implications for diabetes health care professionals», en Diabetes Spectr., 29(1), 2009, pp. 23–25.

[8]. Vetter, M. L., Herring, S. J., Sood, M., Shah, N. R., Kalet, A. L., «What do resident physicians know about nutrition? An evaluation of attitudes, self-perceived proficiency and knowledge», en J Am Coll Nutr., 27(2), 2008, pp. 287–298.

[9]. Lazarus, K., Weinsier, R. L., Boker, J. R., «Nutrition knowledge and practices of physicians in a family-practice residency program: the effect of an education program provided by a physician nutrition specialist», en Am J Clin Nutr., 58(3), 1993, pp. 319–325.

[10]. Senate Committee on Business, Professions and Economic Development. Bill Analysis on SB380, <http://www.leginfo.ca.gov/pub/11-12/bill/sen/sb_0351-0400/sb_380_cfa_20110421_125358_sen_comm.html>. Vista celebrada el 25 de abril de 2011. Último acceso 31 de marzo de 2015.

[11]. The Medical Board of California. Continuing Medical Education, <http://www.mbc.ca.gov/Licensees/Continuing_Education/>, sin fecha de publicación. Último acceso 31 de marzo de 2015.

[12]. «Wizard Edison says doctors of future will give no medicine», en Newark Advocate, 2 de enero de 1903.

[13]. Stange, K. C., Zyzanski, S. J., Jaén, C. R., et al., «Illuminating the “black box”. A description of 4454 patient visits to 138 family physicians», en J Fam Pract., 46(5), 1998, pp. 377–389.

[14]. Aitken, M., «Johns Hopkins Bloomberg School of Public Health. The trillion dollar market for medicines: characteristics, dynamics and outlook», <http://www.jhsph.edu/research/centers-and-institutes/center-for-drug-safety-and-effec tiveness/academic-training/seminar-series/MUrray%20Aikten.pdf>, 24 de febrero de 2014. Último acceso 29 de marzo de 2015.

[15]. Willett, W. C., «Balancing life-style and genomics research for disease prevention», en Science, 296(5568), 2002, pp. 695–698.

[16]. Willett, W. C., «Balancing life-style and genomics research for disease prevention», en Science, 296(5568), 2002, pp. 695–698.

[17]. Robertson, T. L., Kato, H., Rhoads, G. G., et al., «Epidemiologic studies of coronary heart disease and stroke in Japanese men living in Japan, Hawaii and California. Incidence of myocardial infarction and death from coronary heart disease», en Am J Cardiol., 39(2), 1977, pp. 239–243.

[18]. Mayo Clinic News Network, «Nearly 7 in 10 Americans take prescription drugs», Mayo Clinic, Olmsted Medical Center Find., <http://newsnetwork.mayoclinic.org/discussion/nearly-7-in-10-americans-take-prescription-drugs-mayo-clinic-olmsted-medical-center-find/>, 19 de junio de 2013. Último acceso 31 de marzo de 2015.

[19]. Murray, C. J., Atkinson, C., Bhalla, K., et al., «The state of US health, 1990-2010: burden of diseases, injuries, and risk factors», en JAMA, 310(6), 2013, pp. 591–608.

[20]. Crimmins, E. M., Beltrán-Sánchez, H., «Mortality and morbidity trends: is there compression of morbidity?», en J Gerontol B Psychol Sci Soc Sci., 66(1), 2011, pp. 75–86.

[21]. Crimmins, E. M., Beltrán-Sánchez H., «Mortality and morbidity trends: is there compression of morbidity?», en J Gerontol B Psychol Sci Soc Sci., 66(1), 2011, pp. 75–86.

[22]. Olshansky, S. J., Passaro, D. J., Hershow, R. C., et al., «A potential decline in life expectancy in the United States in the 21st century», en N Engl J Med., 352(11), 2005, pp. 1138–1145.

[23]. Offord, D. R., «Selection of levels of prevention», en Addict Behav., 25(6), 2000, pp. 833–842.

[24]. Gofrit, O. N., Shemer, J., Leibovici, D., Modan, B., Shapira, S. C., «Quaternary prevention: a new look at an old challenge», en Isr Med Assoc J., 2(7), 2000, pp. 498–500.

[25]. Strasser, T., «Reflections on cardiovascular diseases», en Interdiscip Sci Rev., 3(3), 1978, pp. 225–230.

[26]. Lloyd-Jones, D. M., Hong, Y., Labarthe, D., et al., «Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association’s strategic Impact Goal through 2020 and beyond», en Circulation, 121(4), 2010, pp. 586–613.

[27]. Yancy, C. W., «Is ideal cardiovascular health attainable?», en Circulation, 123(8), 2011, pp. 835–837.

[28]. Lloyd-Jones, D. M., Hong, Y., Labarthe, D., et al., «Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association’s strategic Impact Goal through 2020 and beyond», en Circulation, 121(4), 2010, pp. 586–613.

[29]. Yusuf, S., Hawken, S., Ounpuu, S., et al., «Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study», en Lancet, 364(9438), 2004, pp. 937–952.

[30]. Lloyd-Jones, D. M., Hong, Y., Labarthe, D., et al., «Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association’s strategic Impact Goal through 2020 and beyond», en Circulation, 121(4), 2010, pp. 586–613.

[31]. Shay, C. M., Ning, H., Allen, N. B., et al., «Status of cardiovascular health in US adults: prevalence estimates from the National Health and Nutrition Examination Surveys (NHANES), 2003–2008», en Circulation, 125(1), 2012, pp. 45–56.

[32]. Shay, C. M., Ning, H., Allen, N. B., et al., «Status of cardiovascular health in US adults: prevalence estimates from the National Health and Nutrition Examination Surveys (NHANES), 2003–2008», en Circulation, 125(1), 2012, pp. 45–56.

[33]. Omran, A. R., «The epidemiologic transition. A theory of the epidemiology of population change», en Milbank Mem Fund Q., 49(4), 1971, pp. 509–538.

[34]. US Centers for Disease Control and Prevention, «Leading causes of death, 1900-1998», <http://www.cdc.gov/nchs/data/dvs/lead1900_98.pdf>. Último acceso 29 de abril de 2015.

[35]. Kochanek, K. D., Murphy, S. L., Xu, J., Arias, E., «Mortality in the United States, 2013», en NCHS Data Brief, 178, 2014.

[36]. Lim, S. S., Vos, T., Flaxman, A. D., et al., «A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010», en Lancet, 380(9859), 2012, pp. 2224–2260.

[37]. Popkin, B. M., «Global nutrition dynamics: the world is shifting rapidly toward a diet linked with noncommunicable diseases», en Am J Clin Nutr., 84(2), 2006, pp. 289–298.

[38]. Zhai, F., Wang, H., Du, S., et al., «Prospective study on nutrition transition in China», en Nutr Rev., 67, 2009, Sup. 1, pp. S56–S61.

[39]. Singh, P. N., Arthur, K. N., Orlich, M. J., et al., «Global epidemiology of obesity, vegetarian dietary patterns, and noncommunicable disease in Asian Indians», en Am J Clin Nutr., 100, 2014, Sup. 1, pp. 359S-364S.

[40]. Singh, P. N., Arthur, K. N., Orlich, M. J., et al., «Global epidemiology of obesity, vegetarian dietary patterns, and noncommunicable disease in Asian Indians», en Am J Clin Nutr., 100, 2014, Sup. 1, pp. 359S-364S.

[41]. McCarty, M. F., «Proposal for a dietary “phytochemical index”», en Med Hypotheses., 63(5), 2004, pp. 813–817.

[42]. Mirmiran, P., Bahadoran, Z., Golzarand, M., Shiva, N., Azizi, F., «Association between dietary phytochemical index and 3–year changes in weight, waist circumference and body adiposity index in adults: Tehran Lipid and Glucose study», en Nutr Metab (Londres), 9(1), 2012, p. 108.

[43]. Mirmiran, P., Bahadoran, Z., Golzarand, M., Shiva, N., Azizi, F., «Association between dietary phytochemical index and 3–year changes in weight, waist circumference and body adiposity index in adults: Tehran Lipid and Glucose study», en Nutr Metab. (Londres), 9(1), 2012, p. 108.

[44]. Golzarand, M., Bahadoran, Z., Mirmiran, P., Sadeghian-Sharif, S., Azizi, F., «Dietary phytochemical index is inversely associated with the occurrence of hypertension in adults: a 3-year follow-up (the Tehran Lipid and Glucose Study)», en Eur J Clin Nutr., 69(3), 2015, pp. 392–398.

[45]. Golzarand, M., Mirmiran, P., Bahadoran, Z., Alamdari, S., Azizi, F., «Dietary phytochemical index and subsequent changes of lipid profile: a 3-year follow-up in Tehran Lipid and Glucose Study in Iran», en ARYA Atheroscler, 10(4), 2014, pp. 203–210.

[46]. Bahadoran, Z., Karimi, Z., Houshiar-Rad, A., Mirzayi, H. R., Rashidkhani, B., «Dietary phytochemical index and the risk of breast cancer: a case control study in a population of Iranian women», en Asian Pac J Cancer Prev., 14(5), 2013, pp. 2747–2751.

[47]. U.S. Department of Agriculture Economic Research Service, «Loss-adjusted food availability», <http://www.ers.usda.gov/datafiles/Food_Availabily_Per_Capita_Data_System/LossAdjusted_Food_Availability/calories.xls>, 30 de septiembre de 2014. Último acceso 29 de abril de 2015.

[48]. Wansink, B., Kniffin, K. M., Shimizu, M., «Death row nutrition. Curious conclusions of last meals», en Appetite, 59(3), 2012, pp. 837–843.

[49]. Bambs, C., Kip, K. E., Dinga, A., Mulukutla, S. R., Aiyer, A. N., Reis, S. E., «Low prevalence of “ideal cardiovascular health” in a community-based population: the heart strategies concentrating on risk evaluation (Heart SCORE) study», en Circulation, 123(8), 2011, pp. 850–857.

[50]. Yancy, C. W., «Is ideal cardiovascular health attainable?», en Circulation, 123(8), 2011, pp. 835–837.

[51]. Ford, E. S., Bergmann, M. M., Krord, J., Schienkiewitz, A., Weikert, C., Boeing, H., «Healthy living is the best revenge: findings from the European Prospective Investigation Into Cancer and Nutrition-Potsdam study», en Arch Intern Med., 169(15), 2009, pp. 1355–1362.

[52]. Platz, E. A., Willett, W. C., Colditz, G. A., Rimm, E. B., Spiegelman, D., Giovannucci, E., «Proportion of colon cancer risk that might be preventable in a cohort of middle-aged US men», en Cancer Causes Control, 11(7), 2000, pp. 579–588.

[53]. Wahls, T. L., «The seventy percent solution», en J Gen Intern Med., 26(10), 2011, pp. 1215–1216.

[54]. Ford, E. S., Bergmann, M. M., Boeing, H., Li, C., Capewell, S., «Healthy lifestyle behaviors and all-cause mortality among adults in the United States», en Prev Med., 55(1), 2012, pp. 23–27.

[55]. Khaw, K. T., Wareham, N., Bingham, S., Welch, A., Luben, R., Day, N., «Combined impact of health behaviours and mortality in men and women: the EPIC-Norfolk prospective population study», en PLoS Med., 5(1), 2008, p. e12.

[56]. Jiang, H., Ju, Z., Rudolph, K. L., «Telomere shortening and ageing», en Z Gerontol Geriatr., 40(5), 2007, pp. 314–324.

[57]. Mather, K. A., Jorm, A. F., Parslow, R. A., Christensen, H., «Is telomere length a biomarker of aging? A review», en J Gerontol A Biol Sci Med Sci., 66(2), 2011, pp. 202–213.

[58]. Tsuji, A., Ishiko, A., Takasaki, T., Ikeda, N., «Estimating age of humans based on telomere shortening», en Forensic Sci Int., 126(3), 2002, pp. 197–199.

[59]. Shammas, M. A., «Telomeres, lifestyle, cancer, and aging», en Curr Opin Clin Nutr Metab Care, 14(1), 2011, pp. 28–34.

[60]. Huzen, J., Wong, L. S., Van Veldhuisen, D. J., et al., «Telomere length loss due to smoking and metabolic traits», en J Intern Med., 275(2), 2014, pp. 155–163.

[61]. Hou, L., Savage, S. A., Blaser, M. J., et al., «Telomere length in peripheral leukocyte DNA and gastric cancer risk», en Cancer Epidemiol Biomarkers Prev., 18(11), 2009, pp. 3103–3109.

[62]. Gu, Y., Honig, L. S., Schupf, N., et al., «Mediterranean diet and leukocyte telomere length in a multiethnic elderly population», en Age (Dordr), 37(2), 2015, p. 9758.

[63]. García-Calzón, S., Moleres, A., Martínez-González, M. A., et al., «Dietary total antioxidant capacity is associated with leukocyte telomere length in a children and adolescent population», en Clin Nutr., S0261–5614(14), 2014, pp. 00191–00195.

[64]. García-Calzón, S., Moleres, A., Martínez-González, M. A., et al., «Dietary total antioxidant capacity is associated with leukocyte telomere length in a children and adolescent population», en Clin Nutr., S0261–5614(14), 2014, pp. 00191–00195.

[65]. Leung, C. W., Laraia, B. A., Needham, B. L., et al., «Soda and cell aging: associations between sugarsweetened beverage consumption and leukocyte telomere length in healthy adults from the National Health and Nutrition Examination Surveys», en Am J Public Health, 104(12), 2014, pp. 2425–2431.

[66]. Nettleton, J. A., Diez-Roux, A., Jenny, N. S., Fitzpatrick, A. L., Jacobs, D. R., «Dietary patterns, food groups, and telomere length in the Multi-Ethnic Study of Atherosclerosis (MESA)», en Am J Clin Nutr., 88(5), 2008, pp. 1405–1412.

[67]. Gu, Y., Honig, L. S., Schupf, N., et al., «Mediterranean diet and leukocyte telomere length in a multiethnic elderly population», en Age (Dordr), 37(2), 2015, p. 9758.

[68]. Flanary, B. E., Kletetschka, G., «Analysis of telomere length and telomerase activity in tree species of various life-spans, and with age in the bristlecone pine Pinus longaeva», en Biogerontology, 6(2), 2005, pp. 101–111.

[69]. Ornish, D., Lin, J., Daubenmier, J., et al., «Increased telomerase activity and comprehensive lifestyle changes: a pilot study», en Lancet Oncol., 9(11), 2008, pp. 1048–1057.

[70]. Skordalakes, E., «Telomerase and the benefits of healthy living», en Lancet Oncol., 9(11), 2008, pp. 1023–1024.

[71]. Ornish, D., Lin, J., Chan, J. M., et al., «Effect of comprehensive lifestyle changes on telomerase activity and telomere length in men with biopsy-proven low-risk prostate cancer: 5-year follow-up of a descriptive pilot study», en Lancet Oncol., 14(11), 2013, pp. 1112–1120.

[72]. Mason, C., Risques, R. A., Xiao, L., et al., «Independent and combined effects of dietary weight loss and exercise on leukocyte telomere length in postmenopausal women», en Obesity (Silver Spring), 21(12), 2013, pp. E549–E554.

[73]. Ornish, D., Lin, J., Daubenmier, J., et al., «Increased telomerase activity and comprehensive lifestyle changes: a pilot study», en Lancet Oncol., 9(11), 2008, pp. 1048–1057.

[74]. Ornish, D., Lin, J., Chan, J. M., et al., «Effect of comprehensive lifestyle changes on telomerase activity and telomere length in men with biopsy-proven low-risk prostate cancer: 5-year follow-up of a descriptive pilot study», en Lancet Oncol., 14(11), 2013, pp. 1112–1120.

[75]. Artandi, S. E., Depinho, R. A., «Telomeres and telomerase in cancer», en Carcinogenesis, 31(1), 2010, pp. 9–18.

[76]. Mozaffarian, D., Benjamin, E. J., Go, A. S., et al., «Heart disease and stroke statistics—2015 update: a report from the American Heart Association», en Circulation, 131(4), 2015, pp. e29–322.

[77]. American Cancer Society, «Cancer Facts & Figures 2015», American Cancer Society, Atlanta, 2015.

[78]. NHLBI, «Fact Book, Fiscal Year 2012», National Heart, Lung, and Blood Institute, NIH, en <http://www.nhlbi.nih.gov/files/docs/factbook/FactBook2012.pdf>, febrero de 2013. Último acceso 31 de marzo de 2015.

[79]. Mozaffarian, D., Benjamin, E. J., Go, A. S., et al., «Heart disease and stroke statistics—2015 update: a report from the American Heart Association», en Circulation, 131(4), 2015, pp. e29–322.

[80]. Centers for Disease Control and Prevention, «Deaths: final data for 2013 table 10. Number of deaths from 113 selected causes», en National Vital Statistics Report, 64(2), 2016.

[81]. American Cancer Society, «Cancer Facts & Figures 2015», American Cancer Society, Atlanta, 2015.

[82]. Centers for Disease Control and Prevention, «Deaths: final data for 2013 table 10. Number of deaths from 113 selected causes», en National Vital Statistics Report, 64(2), 2016.

[83]. Centers for Disease Control and Prevention, «Deaths: final data for 2013 table 10. Number of deaths from 113 selected causes», en National Vital Statistics Report, 64(2), 2016.

[84]. Mozaffarian, D., Benjamin, E. J., Go, A. S., et al., «Heart disease and stroke statistics—2015 update: a report from the American Heart Association», en Circulation, 131(4), 2015, pp. e29–322.

[85]. Centers for Disease Control and Prevention, «Deaths: final data for 2013 table 10. Number of deaths from 113 selected causes», en National Vital Statistics Report, 64(2), 2016.

[86]. American Cancer Society, «Cancer Facts & Figures 2015», American Cancer Society, Atlanta, 2015.

[87]. Centers for Disease Control and Prevention, «Deaths: final data for 2013 table 10. Number of deaths from 113 selected causes», en National Vital Statistics Report, 64(2), 2016.

[88]. Centers for Disease Control and Prevention, «Deaths: final data for 2013 table 10. Number of deaths from 113 selected causes», en National Vital Statistics Report, 64(2), 2016.

[89]. Centers for Disease Control and Prevention, «Deaths: final data for 2013 table 10. Number of deaths from 113 selected causes», en National Vital Statistics Report, 64(2), 2016.

[90]. Centers for Disease Control and Prevention, «Deaths: final data for 2013 table 10. Number of deaths from 113 selected causes», en National Vital Statistics Report, 64(2), 2016.

[91]. Centers for Disease Control and Prevention, «Deaths: final data for 2013 table 10. Number of deaths from 113 selected causes», en National Vital Statistics Report, 64(2), 2016.

[92]. Tuso, P. J., Ismail, M. H., Ha, B. P., Bartolotto, C., «Nutritional update for physicians: plant-based diets», en Perm J., 17(2), 2013, pp. 61–66.

[93]. Egger, G. J., Binns, A. F., Rossner, S. R., «The emergence of “lifestyle medicine” as a structured approach for management of chronic disease», en Med J Aust., 190(3), 2009, pp. 143–145.

[94]. Hyman, M. A., Ornish, D., Roizen, M., «Lifestyle medicine: treating the causes of disease», en Altern Ther Health Med., 15(6), 2009, pp. 12–14.

[95]. Willett, W. C., «Balancing life-style and genomics research for disease prevention», en Science, 296(5568), 2002, pp. 695–698.

[96]. Hyman, M. A., Ornish, D., Roizen, M., «Lifestyle medicine: treating the causes of disease», en Altern Ther Health Med., 15(6), 2009, pp. 12–14.

[97]. Allen, J., Anderson, D. R., Baun, B., et al., «Reflections on developments in health promotion in the past quarter century from founding members of the American Journal of Health Promotion Editorial Board», en Am J Health Promot., 25(4), 2011, pp. ei-eviii.

[98]. Tuso, P. J., Ismail, M. H., Ha, B. P., Bartolotto, C., «Nutritional update for physicians: plant-based diets», en Perm J., 17(2), 2013, pp. 61–66.

[99]. Tuso, P. J., Ismail, M. H., Ha, B. P., Bartolotto, C., «Nutritional update for physicians: plant-based diets», en Perm J., 17(2), 2013, pp. 61–66.

[100]. Tuso, P. J., Ismail, M. H., Ha, B. P., Bartolotto, C., «Nutritional update for physicians: plant-based diets», en Perm J., 17(2), 2013, pp. 61–66.

[101]. Kono, S., «Secular trend of colon cancer incidence and mortality in relation to fat and meat intake in Japan», en Eur J Cancer Prev., 13(2), 2004, pp. 127–132.

[102]. Willett, W. C., «Balancing life-style and genomics research for disease prevention», en Science, 296(5568), 2002, pp. 695–698.

[103]. Kono, S., «Secular trend of colon cancer incidence and mortality in relation to fat and meat intake in Japan», en Eur J Cancer Prev., 13(2), 2004, pp. 127–132.

[104]. Kulshreshtha, A., Goyal, A., Veledar, E., et al., «Association between ideal cardiovascular health and carotid intima-media thickness: a twin study», en J Am Heart Assoc., 3(1), 2014, p. e000282.

[105]. Corona, M., Velarde, R. A., Remolina, S., et al., «Vitellogenin, juvenile hormone, insulin signaling, and queen honey bee longevity», en Proc Natl Acad Sci USA, 104(17), 2007, pp. 7128–7133.

[106]. Kucharski, R., Maleszka, J., Foret, S., Maleszka, R., «Nutritional control of reproductive status in honeybees via DNA methylation», en Science, 319(5871), 2008, pp. 1827–1830.

[107]. Gnyszka, A., Jastrzebski, Z., Flis, S., «DNA methyltransferase inhibitors and their emerging role in epigenetic therapy of cancer», en Anticancer Res., 33(8), 2013, pp. 2989–2996.

[108]. Joven, J., Micol, V., Segura-Carretero, A., Alonso-Villaverde, C., Menéndez, J. A., «Polyphenols and the modulation of gene expression pathways: can we eat our way out of the danger of chronic disease?», en Crit Rev Food Sci Nutr., 54(8), 2014, pp. 985–1001.

[109]. Fang, M. Z., Wang, Y., Ai, N., et al., «Tea polyphenol (-)-epigallocatechin-3-gallate inhibits DNA methyltransferase and reactivates methylation-silenced genes in cancer cell lines», en Cancer Res., 63(22), 2003, pp. 7563–7570.

[110]. Myzak, M. C., Tong, P., Dashwood, W. M., Dashwood, R. H., Ho, E., «Sulforaphane retards the growth of human PC-3 xenografts and inhibits HDAC activity in human subjects», en Exp Biol Med (Maywood), 232(2), 2007, pp. 227–234.

[111]. Dashwood, R. H., Ho, E., «Dietary histone deacetylase inhibitors: from cells to mice to man», en Semin Cancer Biol., 17(5), 2007, pp. 363–369.

[112]. Gryder, B. E., Sodji, Q. H., Oyelere, A. K., «Targeted cancer therapy: giving histone deacetylase inhibitors all they need to succeed», en Future Med Chem., 4(4), 2012, pp. 505–524.

[113]. Ornish, D., Magbanua, M. J., Weidner, G., et al., «Changes in prostate gene expression in men undergoing an intensive nutrition and lifestyle intervention», en Proc Natl Acad Sci USA, 105(24), 2008, pp. 8369–8374.

 

 

 

PRIMERA PARTE

 

1. No morir de enfermedad coronaria

 

[1]. Myerburg, R. J., Junttila, M. J., «Sudden cardiac death caused by coronary heart disease», en Circulation, 28;125(8), 2012, pp. 1043–1052.

[2]. Campbell, T. C., Parpia, B., Chen, J., «Diet, lifestyle, and the etiology of coronary artery disease: the Cornell China study», en Am J Cardiol., 82(10B), 1998, pp. 18T-21T.

[3]. Shaper, A. G., Jones, K. W., «Serum-cholesterol, diet, and coronary heart-disease in Africans and Asians in Uganda: 1959», en Int J Epidemiol., 41(5), 2012, pp. 1221–1225.

[4]. Thomas, W. A., Davies, J. N., O’Neal, R. M., Dimakulangan, A. A., «Incidence of myocardial infarction correlated with venous and pulmonary thrombosis and embolism. A geographic study based on autopsies in Uganda, East Africa and St. Louis, U.S. A.», en Am J Cardiol., 5, 1990, pp. 41–47.

[5]. Benfante, R., «Studies of cardiovascular disease and cause-specific mortality trends in Japanese-American men living in Hawaii and risk factor comparisons with other Japanese populations in the Pacific region: a review», en Hum Biol., 64(6), 1992, pp. 791–805.

[6]. Chen, J., Campbell, T. C., Li, J., Peto, R., Diet, life-style and mortality in China: A study of the characteristics of 65 Chinese counties, Oxford University Press, Nueva York, 1990.

[7]. Shaper, A. G., Jones, K. W., «Serum-cholesterol, diet, and coronary heart-disease in Africans and Asians in Uganda: 1959», en Int J Epidemiol., 41(5), 2012, pp. 1221–1225.

[8]. De Biase, S. G., Fernandes, S. F., Gianini, R. J., Duarte, J. L., «Vegetarian diet and cholesterol and triglycerides levels», en Arq Bras Cardiol., 88(1), 2007, pp. 35–39.

[9]. Stoy, P. J., «Dental disease and civilization», en Ulster Med J., 20(2), 1951, pp. 144–158.

[10]. Kris-Etherton, P. M., Harris, W. S., Appel, L, J., «Nutrition Committee. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease», en Arterioscler Thromb Vasc Biol., 23(2), 2003, pp. e20–e30.

[11]. Shepherd, C. J., Jackson, A. J., «Global fishmeal and fish-oil supply: inputs, outputs and markets», en J Fish Biol., 83(4), 2013, pp. 1046–1066.

[12]. Rizos, E. C., Ntzani, E. E., Bika, E., Kostapanos, M. S., Elisaf, M. S., «Association between omega-3 fatty acid supplementation and risk of major cardiovascular disease events: a systematic review and meta-analysis», en JAMA, 308(10), 2012, pp. 1024–1033.

[13]. Kwak, S. M., Myung, S. K., Lee, Y. J., Seo, H. G., «Efficacy of omega-3 fatty acid supplements (eicosapentaenoic acid and docosahexaenoic acid) in the secondary prevention of cardiovascular disease: a meta-analysis of randomized, double-blind, placebo-controlled trials», en Arch Intern Med., 172(9), 2012, pp. 686–694.

[14]. Fodor, J. G., Helis, E., Yazdekhasti, N., Vohnout, B., «“Fishing” for the origins of the “Eskimos and heart disease” story: facts or wishful thinking?», en Can J Cardiol., 30(8), 2014, pp. 864–868.

[15]. Burr, M. L., Fehily, A. M., Gilbert, J. F., et al., «Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART)», en Lancet, 2(8666), 1989, pp. 757–761.

[16]. Burr, M. L., «Secondary prevention of CHD in UK men: the Diet and Reinfarction Trial and its sequel», en Proc Nutr Soc., 66(1), 2007, pp. 9–15.

[17]. Burr, M. L., Ashfield-Watt, P. A. L., Dunstan, F. D. J., et al., «Lack of benefit of dietary advice to men with angina: results of a controlled trial», en Eur J Clin Nutr., 57(2), 2003, pp. 193–200.

[18]. Rizos, E. C., Ntzani, E. E., Bika, E., Kostapanos, M. S., Elisaf, M. S., «Association between omega-3 fatty acid supplementation and risk of major cardiovascular disease events: a systematic review and meta-analysis», en JAMA, 308(10), 2012, pp. 1024–1033.

[19]. Smith, D. A., «ACP Journal Club. Review: omega-3 polyunsaturated fatty acid supplements do not reduce major cardiovascular events in adults», en Ann Intern Med., 157(12), 2012, pp. JC6–5.

[20]. Enos, W. F., Holmes, R. H., Beyer, J., «Coronary disease among United States soldiers killed in action in Korea; preliminary report», en JAMA, 152(12), 1953, pp. 1090–1093.

[21]. Strong, J. P., «Landmark perspective: Coronary atherosclerosis in soldiers. A clue to the natural history of atherosclerosis in the young», en JAMA, 256(20), 1986, pp. 2863–2866.

[22]. Voller, R. D., Strong, W. B., «Pediatric aspects of atherosclerosis», en Am Heart J., 101(6), 1981, pp. 815–836.

[23]. Napoli, C., D’Armiento, F. P., Mancini, F. P., et al., «Fatty streak formation occurs in human fetal aortas and is greatly enhanced by maternal hypercholesterolemia. Intimal accumulation of low density lipoprotein and its oxidation precede monocyte recruitment into early atherosclerotic lesions», en J Clin Invest., 100(11), 1997, pp. 2680–2690.

[24]. Benjamin, M. M., Roberts, W. C., «Facts and principles learned at the 39th Annual Williamsburg Conference on Heart Disease», en Proc (Bayl Univ Med Cent), 26(2), 2013, pp. 124–136.

[25]. McMahan, C. A., Gidding, S. S., Malcom, G. T., et al., «Pathobiological determinants of atherosclerosis in youth risk scores are associated with early and advanced atherosclerosis», en Pediatrics, 118(4), 2006, pp. 1447–1455.

[26]. Trumbo, P. R., Shimakawa, T., «Tolerable upper intake levels for trans fat, saturated fat, and cholesterol», en Nutr Rev., 69(5), 2011, pp. 270–278.

[27]. Roberts, W. C., «It’s the cholesterol, stupid!», en Am J Cardiol., 106(9), 2010, pp. 1364–1366.

[28]. O’Keefe, J. H., Cordain, L., Harris, W. H., Moe, R. M., Vogel, R., «Optimal low-density lipoprotein is 50 to 70 mg/dl: lower is better and physiologically normal», en J Am Coll Cardiol., 43(11), 2004, pp. 2142–2146.

[29]. Esselstyn, C. B., «In cholesterol lowering, moderation kills», en Cleve Clin J Med., 67(8), 2000, pp. 560–564.

[30]. Roberts, W. C., «The cause of atherosclerosis», en Nutr Clin Pract., 23(5), 2008, pp. 464–467.

[31]. Roberts, W. C., «The cause of atherosclerosis», en Nutr Clin Pract., 23(5), 2008, pp. 464–467.

[32]. King, S., «The best selling drugs since 1996 -why AbbVie’s Humira is set to eclipse Pfizer’s Lipitor», en <http://www.forbes.com/sites/simonking/2013/07/15/the-best-selling-drugs-since-1996–why-abbvies-humira-is-set-to-eclipse-pfizers-lipitor/>, 15 de julio de 2015. Último acceso 1 de mayo de 2015.

[33]. Ginter, E., Kajaba, I., Sauša, M., «Addition of statins into the public water supply? Risks of side effects and low cholesterol levels», en Cas Lek Cesk., 151(5), 2012, pp. 243–247.

[34]. Ferenczi, E. A., Asaria, P., Hughes, A. D., Chaturvedi, N., Francis, D. P., «Can a statin neutralize the cardiovascular risk of unhealthy dietary choices?», en Am J Cardiol., 106(4), 2010, pp. 587–592.

[35]. Draeger, A., Monastyrskaya, K., Mohaupt, M., et al., «Statin therapy induces ultrastructural damage in skeletal muscle in patients without myalgia», en J Pathol., 210(1), 2006, pp. 94–102.

[36]. Scott, D., Blizzard, L., Fell, J., Jones, G., «Statin therapy, muscle function and falls risk in community dwelling older adults», en QJM., 102(9), 2009, pp. 625–633.

[37]. Jefferson, E., «FDA announces safety changes in labeling for some cholesterol-lowering drugs», en la página web de la US Food and Drug Administration, <http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm293623.htm>, 28 de febrero de 2012. Último acceso 14 de febrero de 2015.

[38]. McDougall, J. A., Malone, K. E., Daling, J. R., Cushing-Haugen, K. L., Porter, P. L., Li, C. I., «Long-term statin use and risk of ductal and lobular breast cancer among women 55 to 74 years of age», en Cancer Epidemiol Biomarkers Prev., 22(9), 2013, pp. 1529–1537.

[39]. Jenkins, D. J., Kendall, C. W., Marchie, A., et al., «The Garden of Eden—plant based diets, the genetic drive to conserve cholesterol and its implications for heart disease in the 21st century», en Comp Biochem Physiol, Part A Mol Integr Physiol., 136(1), 2003, pp. 141–151.

[40]. Esselstyn, C. B., «Is the present therapy for coronary artery disease the radical mastectomy of the twenty-first century?», en Am J Cardiol., 106(6), 2010, pp. 902–904.

[41]. Kadoch, M. A., «The power of nutrition as medicine», en Prev Med., 55(1), 2012, p. 80.

[42]. Wakai, K., Marugame, T., Kuriyama, S., et al., «Decrease in risk of lung cancer death in Japanese men after smoking cessation by age at quitting: pooled analysis of three large-scale cohort studies», en Cancer Sci., 98(4), 2007, pp. 584–589.

[43]. Vogel, R. A., Corretti, M. C., Plotnick, G. D., «Effect of a single high-fat meal on endothelial function in healthy subjects», en Am J Cardiol., 79(3), 1997, pp. 350–354.

[44]. Erridge, C., «The capacity of foodstuffs to induce innate immune activation of human monocytes in vitro is dependent on food content of stimulants of Toll-like receptors 2 and 4», en Br J Nutr., 105(1), 2011, pp. 15–23.

[45]. Ornish, D., Scherwitz, L. W., Billings, J. H., et al., «Intensive lifestyle changes for reversal of coronary heart disease», en JAMA, 280(23), 1998, pp. 2001–2007.

[46]. Ornish, D., Scherwitz, L. W., Doody, R. S., et al., «Effects of stress management training and dietary changes in treating ischemic heart disease», en JAMA, 249(1), 1983, pp. 54–59.

[47]. Ornish, D., Scherwitz, L. W., Billings, J. H., et al., «Intensive lifestyle changes for reversal of coronary heart disease», en JAMA, 280(23), 1998, pp. 2001–2007.

[48]. Ellis, F. R., Sanders, T. A., «Angina and vegan diet», en Am Heart J., 93(6), 1997, pp. 803–805.

[49]. Sweeney, M., «Effects of very low-fat diets on anginal symptoms», en Med Hypotheses, 63(3), 2004, p. 553.

[50]. Savarese, G., Rosano, G., D’amore, C., et al., «Effects of ranolazine in symptomatic patients with stable coronary artery disease. A systematic review and meta-analysis», en Int J Cardiol., 169(4), 2013, pp. 262–270.

[51]. Colpo, E., Vilanova, C. D., Brenner Reetz, L. G., et al., «A single consumption of high amounts of the Brazil nuts improves lipid profile of healthy volunteers», en J Nutr Metab., 2013, pp. 1–7.

[52]. Stern, R. H., Yang, B. B., Hounslow, N. J., et al., «Pharmacodynamics and pharmacokinetic-pharmacodynamic relationships of atorvastatin, an HMG-CoA reductase Inhibitor», en J Clin Pharmacol., 40(6), 2000, pp. 616–623.

[53]. Hegsted, M., «Dietary Guidelines», en la página web de la Food Politics, <www.foodpolitics.com/wp-content/uploads/Hegsted.pdf>, sin fecha. Último acceso 14 de febrero de 2015.

[54]. Campbell, T. C., The Low-Carb Fraud, BenBella Books, Inc., Dallas, TX, 2014.

[55]. Herman, J., «Saving U.S. dietary advice from conflicts of interest», en Food and Drug Law Journal, 65(20), 2010, pp. 285–316.

[56]. Herman, J., «Saving U.S. dietary advice from conflicts of interest», en Food and Drug Law Journal, 65(20), 2010, pp. 285–316.

[57]. Goodwin, J. S., Goodwin, J. M., «The tomato effect. Rejection of highly efficacious therapies», en JAMA, 251(18), 1984, pp. 2387–2390.

[58]. Adams, K. M., Kohlmeier, M., Zeisel, S. H., «Nutrition education in U.S. medical schools: latest update of a national survey», en Acad Med., 85(9), 2010, pp. 1537–1542.

[59]. Vista oral del Senado de California sobre la ley 380, en la página web de Vimeo, <http://vimeo.com/23744792>, 25 de abril de 2011. Último acceso 14 de febrero de 2015.

[60]. Murray, J. L., «Coke and the AAFP—the real thing or a dangerous liaison?», en Fam Med., 42(1), 2010, pp. 57–58.

[61]. Blum, A., «AAFP-Coke editorial was music to [our] ears», en J Fam Pract., 59(2), 2010, p. 74.

[62]. Brownell, K. D., Warner, K. E., «The perils of ignoring history: Big Tobacco played dirty and millions died. How similar is Big Food?», en Milbank Q., 87(1), 2009, pp. 259–294.

[63]. Brownell, K. D., Warner, K. E., «The perils of ignoring history: Big Tobacco played dirty and millions died. How similar is Big Food?», en Milbank Q., 87(1), 2009, pp. 259–294.

[64]. Simon, M., «AND now a word from our sponsors», en la página web de la Eat Drinks Politics, <http://www.eatdrinkpolitics.com/wp-content/uploads/AND_Corporate_Sponsorship_ Report.pdf>, 22 de enero de 2013. Último acceso 14 de febrero de 2015.

[65]. Bruckert, E., Pouchain, D., Auboiron, S., Mulet, C., «Cross-analysis of dietary prescriptions and adherence in 356 hypercholesterolaemic patients», en Arch Cardiovasc Dis., 105(11), 2012, pp. 557–565.

[66]. Barnard, N. D., «The physician’s role in nutrition-related disorders: from bystander to leader», en Virtual Mentor, 15(4), 2013, pp. 367–372.

 

 

2. No morir de una enfermedad pulmonar

 

[1]. American Cancer Society, «Cancer Facts & Figures 2015», American Cancer Society, Atlanta, 2015.

[2]. Howlader, N., Noone, A. M., Krapcho, M., et al., (comps.), «SEER Cancer Statistics Review, 1975–2011», National Cancer Institute, en <http://seer.cancer.gov/csr/1975_2011/>, abril de 2014. Último acceso 27 de febrero de 2015.

[3]. American Lung Association, «Lung Cancer Fact Sheet», en <http://www.lung.org/lung-disease/lung-cancer/resources/facts-figures/lung-cancer-fact-sheet.html>. Último acceso 14 de febrero de 2015.

[4]. Moodie, R., Stuckler, D., Monteiro, C., et al., «Profits and pandemics: prevention of harmful effects of tobacco, alcohol, and ultra-processed food and drink industries», en Lancet, 381 (9867), 2013, pp. 670–679.

[5]. American Cancer Society, «When smokers quit—what are the benefits over time?», en <http://www.cancer.org/healthy/stayawayfromtobacco/guidetoquittings moking/guide-to-quitting-smoking-benefits>, 6 de febrero de 2015. Último acceso 26 de febrero de 2015.

[6]. US Department of Health and Human Services, «A Report of the Surgeon General. How Tobacco Smoke Causes Disease: What It Means to You», US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, Atlanta, 2010.

[7]. Riso, P., Martini, D., Møller, P., et al., «DNA damage and repair activity after broccoli intake in young healthy smokers», en Mutagenesis, 25(6), 2010, pp. 595–602.

[8]. Gupta, G. P., Massagué, J., «Cancer metastasis: building a framework», en Cell., 127(4), 2006, pp. 679–695.

[9]. Wu, X., Zhu, Y., Yan, H., et al., «Isothiocyanates induce oxidative stress and suppress the metastasis potential of human non-small cell lung cancer cells», en BMC Cancer, 10, 2010, p. 269.

[10]. Kim, S. Y., Yoon, S., Kwon, S. M., Park, K. S., Lee-Kim, Y. C., «Kale juice improves coronary artery disease risk factors in hypercholesterolemic men», en Biomed Environ Sci., 21(2), 2008, pp. 91–97.

[11]. Dressendorfer, R. H., Wade, C. E., Hornick, C., Timmis, G. C., «High-density lipoprotein-cholesterol in marathon runners during a 20-day road race», en JAMA, 247(12), 1982, pp. 1715–1717.

[12]. Park, W., Amin, A. R., Chen, Z. G., Shin, D. M., «New perspectives of curcumin in cancer prevention», en Cancer Prev Res. (Filadelfia), 6(5), 2013, pp. 387–400.

[13]. Park, W., Amin, A. R., Chen, Z. G., Shin, D. M., «New perspectives of curcumin in cancer prevention», en Cancer Prev Res. (Filadelfia), 6(5), 2013, pp. 387–400.

[14]. Nagabhushan, M., Amonkar, A. J., Bhide, S. V., «In vitro antimutagenicity of curcumin against environmental mutagens», en Food Chem Toxicol., 25(7), 1987, pp. 545–547.

[15]. Polasa, K., Raghuram, T. C., Krishna, T. P., Krishnaswamy, K., «Effect of turmeric on urinary mutagens in smokers», en Mutagenesis, 7(2), 1992, pp. 107–109.

[16]. Ravindran, J., Prasad, S., Aggarwal, B. B., «Curcumin and cancer cells: how many ways can curry kill tumor cells selectively?», en AAPS J., 11(3), 2009, pp. 495–510.

[17]. Wu, S. H., Hang, L. W., Yang, J. S., et al., «Curcumin induces apoptosis in human non-small cell lung cancer NCI-H460 cells through ER stress and caspase cascade-and mitochondria-dependent pathways», en Anticancer Res., 30(6), 2010, pp. 2125–2133.

[18]. Su, C. C., Lin, J. G., Li, T. M., et al., «Curcumin-induced apoptosis of human colon cancer colo 205 cells through the production of ROS, Ca2+ and the activation of caspase-3», en Anticancer Res., 26(6B), 2006, pp. 4379–4389.

[19]. Ravindran, J., Prasad, S., Aggarwal, B. B., «Curcumin and cancer cells: how many ways can curry kill tumor cells selectively?», en AAPS J., 11(3), 2009, pp. 495–510.

[20]. Ravindran, J., Prasad, S., Aggarwal, B. B., «Curcumin and cancer cells: how many ways can curry kill tumor cells selectively?», en AAPS J., 11(3), 2009, pp. 495–510.

[21]. Pallis, A. G., Syrigos, K. N., «Lung cancer in never smokers: disease characteristics and risk factors», en Crit Rev Oncol Hematol., 88(3), 2013, pp. 494– 503.

[22]. Chiang, T. A., Wu, P. F., Wang, L. F., Lee, H., Lee, C. H., Ko, Y. C., «Mutagenicity and polycyclic aromatic hydrocarbon content of fumes from heated cooking oils produced in Taiwan», en Mutat Res., 381(2), 1997, pp. 157–161.

[23]. Katragadda, H. R., Fullana, A., Sidhu, S., Carbonell Barrachina, A. A., «Emissions of volatile aldehydes from heated cooking oils», en Food Chem., 120(1), 2010, pp. 59–65.

[24]. Jin, Z. Y., Wu, M., Han, R. Q., et al., «House hold ventilation may reduce effects of indoor air pollutants for prevention of lung cancer: a case-control study in a Chinese population», en PLoS ONE, 9(7), 2014, p. e102685.

[25]. Seow, A., Poh, W. T., The, M., et al., «Fumes from meat cooking and lung cancer risk in Chinese women», en Cancer Epidemiol Biomarkers Prev., 9(11), 2000, pp. 1215–1221.

[26]. Jedrychowski, W., Perera, F. P., Tang, D., et al., «Impact of barbecued meat consumed in pregnancy on birth outcomes accounting for personal prenatal exposure to airborne polycyclic aromatic hydrocarbons: birth cohort study in Poland», en Nutrition, 28(4), 2012, pp. 372–377.

[27]. Perera, F. P., Li, Z., Whyatt, R., et al., «Prenatal airborne polycyclic aromatic hydrocarbon exposure and child IQ at age 5 years», en Pediatrics, 124(2), 2009, pp. e195–202.

[28]. Chen, J. W., Wang, S. L., Hsieh, D. P., Yang, H. H., Lee, H. L., «Carcinogenic potencies of polycyclic aromatic hydrocarbons for back-door neighbors of restaurants with cooking emissions», en Sci Total Environ., 417–418, 2012, pp. 68–75.

[29]. Yang, S. C., Jenq, S. N., Kang, Z. C., Lee, H., «Identification of benzo[a]-pyrene 7,8-diol 9,10-epoxide N2-deoxyguanosine in human lung adenocarcinoma cells exposed to cooking oil fumes from frying fish under domestic conditions», en Chem Res Toxicol., 13(10), 2000, pp. 1046–1050.

[30]. Chen, J. W., Wang, S. L., Hsieh, D. P., Yang, H. H., Lee, H. L., «Carcinogenic potencies of polycyclic aromatic hydrocarbons for back-door neighbors of restaurants with cooking emissions», en Sci Total Environ., 417–418, 15 de febrero de 2012, pp. 68–75.

[31]. Lijinsky, W., «N-Nitroso compounds in the diet», en Mutat Res., 443(1–2), 15 de julio de 1999, pp. 129–138.

[32]. Thiébaud, H. P., Knize, M. G., Kuzmicky, P. A., Hsieh, D. P., Felton, J. S., «Airborne mutagens produced by frying beef, pork and a soy-based food», en Food Chem Toxicol., 33(10), 1995, pp. 821–828.

[33]. Thiébaud, H. P., Knize, M. G., Kuzmicky, P. A., Hsieh, D. P., Felton, J. S., «Airborne mutagens produced by frying beef, pork and a soy-based food», en Food Chem Toxicol., 33(10), 1995, pp. 821–828.

[34]. Mitsakou, C., Housiadas, C., Eleftheriadis, K., Vratolis, S., Helmis, C., Asimakopoulos, D., «Lung deposition of fine and ultrafine particles outdoors and indoors during a cooking event and a no activity period», en Indoor Air, 17(2), 2007, pp. 143–152.

[35]. «COPD Statistics across America», página web de la COPD Foundation, <http://www.copdfoundation.org/What-is-COPD/COPD-Facts/Statistics.aspx>, 2015. Último acceso 14 de febrero de 2015.

[36]. Tabak, C., Smit, H. A., Räsänen, L., et al., «Dietary factors and pulmonary function: a cross sectional study in middle-aged men from three European countries», en Thorax, 54(11), 1999, pp. 1021–1026.

[37]. Walda, I. C., Tabak, C., Smit, H. A., et al., «Diet and 20-year chronic obstructive pulmonary disease mortality in middle-aged men from three European countries», en Eur J Clin Nutr., 56(7), 2002, pp. 638–643.

[38]. Varraso, R., Jiang, R., Barr, R. G., Willett, W. C., Camargo, C. A. Jr., «Prospective study of cured meats consumption and risk of chronic obstructive pulmonary disease in men», en Am J Epidemiol., 166(12), 15 de diciembre de 2007, pp. 1438–1445.

[39]. Jiang, R., Paik, D. C., Hankinson, J. L., Barr, R. G., «Cured meat consumption, lung function, and chronic obstructive pulmonary disease among United States adults», en Am J Respir Crit Care Med., 175(8), 15 de abril de 2007, pp. 798–804.

[40]. Jiang, R., Camargo, C. A., Varraso, R., Paik, D. C., Willett, W. C., Barr, R. G., «Consumption of cured meats and prospective risk of chronic obstructive pulmonary disease in women», en Am J Clin Nutr., 87(4), 2008, pp. 1002–1008.

[41]. Keranis, E., Makris, D., Rodopoulou, P., et al., «Impact of dietary shift to higher-antioxidant foods in COPD: a randomised trial», en Eur Respir J., 36(4), 2010, pp. 774–780.

[42]. Warner, J. O., «Worldwide variations in the prevalence of atopic symptoms: what does it all mean?», en Thorax, 54 Suppl 2, 1999, pp. S46–51.

[43]. «What Is Asthma?», National Heart, Lung, and Blood Institute, en <http://www.nhlbi.nih.gov/health/health-topics/topics/asthma/>, 4 de agosto de 2014. Último acceso 14 de febrero de 2015.

[44]. Warner, J. O., «Worldwide variations in the prevalence of atopic symptoms: what does it all mean?», en Thorax, 54 Suppl 2, 1999, pp. S46–51.

[45]. Aït-Khaled, N., Pearce, N., Anderson, H. R., et al., «Global map of the prevalence of symptoms of rhinoconjunctivitis in children: The International Study of Asthma and Allergies in Childhood (ISAAC) Phase Three», en Allergy, 64(1), 2009, pp. 123–148.

[46]. Asher, M. I., Stewart, A. W., Mallol, J., et al., «Which population level environmental factors are associated with asthma, rhinoconjunctivitis and eczema? Review of the ecological analyses of ISAAC Phase One», en Respir Res., 11, 2010, p. 8.

[47]. Ellwood, P., Asher, M. I., Björkstén, B., Burr, M., Pearce, N., Robertson, C. F., «Diet and asthma, allergic rhinoconjunctivitis and atopic eczema symptom prevalence: an ecological analysis of the International Study of Asthma and Allergies in Childhood (ISAAC) data. ISAAC Phase One Study Group», en Eur Respir J., 17(3), 2001, pp. 436–443.

[48]. Protudjer, J. L., Sevenhuysen, G. P., Ramsey, C. D., Kozyrskyj, A. L., Becker, A. B., «Low vegetable intake is associated with allergic asthma and moderate-to-severe airway hyperresponsiveness», en Pediatr Pulmonol., 47(12), 2012, pp. 1159–1169.

[49]. Bime, C., Wei, C. Y., Holbrook, J., Smith, L. J., Wise, R. A., «Association of dietary soy genistein intake with lung function and asthma control: a post-hoc analysis of patients enrolled in a prospective multicentre clinical trial», en Prim Care Respir J., 21(4), 2012, pp. 398–404.

[50]. Agrawal, S., Pearce, N., Ebrahim, S., «Prevalence and risk factors for self-reported asthma in an adult Indian population: a cross-sectional survey», en Int J Tuberc Lung Dis., 17(2), 2013, pp. 275–282.

[51]. Tsai, H. J., Tsai, A. C., «The association of diet with respiratory symptoms and asthma in school children in Taipei, Taiwan», en J Asthma, 44(8), 2007, pp. 599–603.

[52]. Yusoff, N. A., Hampton, S. M., Dickerson, J. W., Morgan, J. B., «The effects of exclusion of dietary egg and milk in the management of asthmatic children: a pilot study», en J R Soc Promot Health, 124(2), 2004, pp. 74–80.

[53]. Wood, L. G., Garg, M. L., Blake, R. J., Garcia-Caraballo, S., Gibson, P. G., «Airway and circulating levels of carotenoids in asthma and healthy controls», en J Am Coll Nutr., 24(6), 2005, pp. 448–455.

[54]. Miller, E. R., Appel, L. J., Risby, T. H., «Effect of dietary patterns on measures of lipid peroxidation: results from a randomized clinical trial», en Circulation, 98(22), 1998, pp. 2390–2395.

[55]. Wood, L. G., Garg, M. L., Smart, J. M., Scott, H. A., Barker, D., Gibson, P. G., «Manipulating antioxidant intake in asthma: a randomized controlled trial», en Am J Clin Nutr., 96(3), 2012, pp. 534–543.

[56]. Wood, L. G., Garg, M. L., Smart, J. M., Scott, H. A., Barker, D., Gibson, P. G., «Manipulating antioxidant intake in asthma: a randomized controlled trial», en Am J Clin Nutr., 96(3), 2012, pp. 534–543.

[57]. Patel, S., Murray, C. S., Woodcock, A., Simpson, A., Custovic, A., «Dietary antioxidant intake, allergic sensitization and allergic diseases in young children», en Allergy, 64(12), 2009, pp. 1766–1772.

[58]. Troisi, R. J., Willett, W. C., Weiss, S. T., Trichopoulos, D., Rosner, B., Speizer, F. E., «A prospective study of diet and adult-onset asthma», en Am J Respir Crit Care Med., 151(5), 1995, pp. 1401–1408.

[59]. Wood, L. G., Garg, M. L., Smart, J. M., Scott, H. A., Barker, D., Gibson, P. G., «Manipulating antioxidant intake in asthma: a randomized controlled trial», en Am J Clin Nutr., 96(3), 2012, pp. 534–543.

[60]. Lindahl, O., Lindwall, L., Spångberg, A., Stenram, A., Ockerman, P. A., «Vegan regimen with reduced medication in the treatment of bronchial asthma», en J Asthma, 22(1), 1985, pp. 45–55.

[61]. Lindahl, O., Lindwall, L., Spångberg, A., Stenram, A., Ockerman, P. A., «Vegan regimen with reduced medication in the treatment of bronchial asthma», en J Asthma, 22(1), 1985, pp. 45–55.

[62]. Lindahl, O., Lindwall, L., Spångberg, A., Stenram, A., Ockerman, P. A., «Vegan regimen with reduced medication in the treatment of bronchial asthma», en J Asthma, 22(1), 1985, pp. 45–55.

 

 

3. No morir de una enfermedad cerebral

 

[1]. Mozaffarian, D., Benjamin, E. J., Go, A. S., et al., «Heart disease and stroke statistics—2015 update: a report from the American Heart Association», en Circulation, 131(4), 2015, pp. e29–322.

[2]. Centers for Disease Control and Prevention, «Deaths: final data for 2013 table 10. Number of deaths from 113 selected causes», en National Vital Statistics Report, 64(2), 2016.

[3]. Mozaffarian, D., Benjamin, E. J., Go, A. S., et al., «Heart disease and stroke statistics—2015 update: a report from the American Heart Association», en Circulation, 131(4), 2015, pp. e29–322.

[4]. Grau-Olivares, M., Arboix, A., «Mild cognitive impairment in stroke patients with ischemic cerebral small-vessel disease: a forerunner of vascular dementia?», en Expert Rev Neurother., 9(8), 2009, pp. 1201–1217.

[5]. Aune, D., Chan, D. S., Lau, R., et al., «Dietary fibre, whole grains, and risk of colorectal cancer: systematic review and dose-response meta-analysis of prospective studies», en BMJ, 343, 2011, p. d6617.

[6]. Aune, D., Chan, D. S., Greenwood, D. C., et al., «Dietary fiber and breast cancer risk: a systematic review and meta-analysis of prospective studies», en Ann Oncol., 23(6), 2012, pp. 1394–1402.

[7]. Yao, B., Fang, H., Xu, W., et al., «Dietary fiber intake and risk of type 2 diabetes: a dose-response analysis of prospective studies», en Eur J Epidemiol., 29(2), 2014, pp. 79–88.

[8]. Threapleton, D. E., Greenwood, D. C., Evans, C. E., et al., «Dietary fibre intake and risk of cardiovascular disease: systematic review and meta-analysis», en BMJ, 347, 2013, p. f6879.

[9]. Maskarinec, G., Takata, Y., Pagano, I., et al., «Trends and dietary determinants of overweight and obesity in a multiethnic population», en Obesity (Silver Spring), 14(4), 2006, pp. 717–726.

[10]. Kim, Y., Je, Y., «Dietary fiber intake and total mortality: a meta-analysis of prospective cohort studies», en Am J Epidemiol., 180(6), 2014, pp. 565–573.

[11]. Threapleton, D. E., Greenwood, D. C., Evans, C. E., et al., «Dietary fiber intake and risk of first stroke: a systematic review and meta-analysis», en Stroke, 44(5), 2013, pp. 1360–1368.

[12]. Clemens, R., Kranz, S., Mobley, A. R., et al., «Filling America’s fiber intake gap: summary of a roundtable to probe realistic solutions with a focus on grain-based foods», en J Nutr., 142(7), 2012, pp. 1390S-1401S.

[13]. Threapleton, D. E., Greenwood, D. C., Evans, C. E., et al., «Dietary fiber intake and risk of first stroke: a systematic review and meta-analysis», en Stroke, 44(5), 2013, pp. 1360–1368.

[14]. Whitehead, A., Beck, E. J., Tosh, S., Wolever, T. M., «Cholesterol-lowering effects of oat β-glucan: a meta-analysis of randomized controlled trials», en Am J Clin Nutr., 100(6), 2014, pp. 1413–1421.

[15]. Silva, F. M., Kramer, C. K., De Almeida, J. C., Steemburgo, T., Gross, J. L., Azevedo, M. J., «Fiber intake and glycemic control in patients with type 2 diabetes mellitus: a systematic review with meta-analysis of randomized controlled trials», en Nutr Rev., 71(12), 2013, pp. 790–801.

[16]. Streppel, M. T., Arends, L. R., Van ’t Veer, P., Grobbee, D. E., Geleijnse, J. M., «Dietary fiber and blood pressure: a meta-analysis of randomized placebo-controlled trials», en Arch Intern Med., 165(2), 2005, pp. 150–156.

[17]. Centers for Disease Control and Prevention, «Deaths: final data for 2013 table 10. Number of deaths from 113 selected causes», en National Vital Statistics Report, 64(2), 2016.

[18]. Van de Laar, R. J., Stehouwer, C. D. A., Van Bussel, B. C. T., et al., «Lower lifetime dietary fiber intake is associated with carotid artery stiff ness: the Amsterdam Growth and Health Longitudinal Study», en Am J Clin Nutr., 96(1), 2012, pp. 14–23.

[19]. Van de Laar, R. J., Stehouwer, C. D. A., Van Bussel, B. C. T., et al., «Lower lifetime dietary fiber intake is associated with carotid artery stiff ness: the Amsterdam Growth and Health Longitudinal Study», en Am J Clin Nutr., 96(1), 2012, pp. 14–23.

[20]. Casiglia, E., Tikhonoff, V., Caffi, S., et al., «High dietary fiber intake prevents stroke at a population level», en Clin Nutr., 32(5), 2013, pp. 811–818.

[21]. Tikhonoff, V., Palatini, P., Casiglia, E., en una carta de Tikhonoff et al. en relación con el artículo: «Dietary fiber intake and risk of first stroke: a systematic review and meta-analysis», en Stroke, 44(9), 2013, p. e109.

[22]. Threapleton, D. E., Greenwood, D. C., Burley, V. J., en respuesta a una carta sobre el artículo: «Dietary fiber intake and risk of first stroke: a systematic review and meta-analysis», en Stroke, 44(9), 2013, p. e110.

[23]. Eaton, S. B., Konner, M., «Paleolithic nutrition. A consideration of its nature and current implications», en N Engl J Med., 312(5), 1985, pp. 283–289.

[24]. Cogswell, M. E., Zhang, Z., Carriquiry, A. L., et al., «Sodium and potassium intakes among US adults: NHANES 2003–2008», en Am J Clin Nutr., 96(3), 2012, pp. 647–657.

[25]. Cogswell, M. E., Zhang, Z., Carriquiry, A. L., et al., «Sodium and potassium intakes among US adults: NHANES 2003–2008», en Am J Clin Nutr., 96(3), 2012, pp. 647–657.

[26]. D’Elia, L., Barba, G., Cappuccio, F. P., et al., «Potassium intake, stroke, and cardiovascular disease a meta-analysis of prospective studies», en J Am Coll Cardiol., 57(10), 2011, pp. 1210–1219.

[27]. U.S. Department of Agriculture, «USDA National Nutrient Database for Standard Reference», en <http://ndb.nal.usda.gov/ndb/nutrients/index?fg=&nutrient1=306&nutrient2=&nutrient3=&subset=0&sort=c&totCount=0&offset=0&measureby=g>, 2011. Último acceso 1 de abril de 2015.

[28]. «U.S. Department of Agriculture Dietary Guidelines for Americans 2005. Appendix B-1. Food sources of potassium», en <http://www.health.gov/dietaryguidelines/dga2005/document/html/appendixb.htm>, 9 de julio de 2008. Último acceso 1 de mayo de 2015.

[29]. Hu, D., Huang, J., Wang, Y., Zhang, D., Qu, Y., «Fruits and vegetables consumption and risk of stroke: a meta-analysis of prospective cohort studies», en Stroke, 45(6), 2014, pp. 1613–1619.

[30]. Morand, C., Dubray, C., Milenkovic, D., et al., «Hesperidin contributes to the vascular protective effects of orange juice: a randomized crossover study in healthy volunteers», en Am J Clin Nutr., 93(1), 2011, pp. 73–80.

[31]. Takumi, H., Nakamura, H., Simizu, T., et al., «Bioavailability of orally administered water-dispersible hesperetin and its effect on peripheral vasodilatation in human subjects: implication of endothelial functions of plasma conjugated metabolites», en Food Funct., 3(4), 2012, pp. 389–398.

[32]. Patyar, S., Patyar, R. R., «Correlation between sleep duration and risk of stroke», en J Stroke Cerebrovasc Dis., 24(5), 2015, pp. 905–911.

[33]. Ikehara, S., Iso, H., Date, C., et al., JACC Study Group, «Association of sleep duration with mortality from cardiovascular disease and other causes for Japanese men and women: the JACC study», en Sleep, 32(3), 2009, pp. 295–301.

[34]. Fang, J., Wheaton, A. G., Ayala, C., «Sleep duration and history of stroke among adults from the USA», en J Sleep Res., 23(5), 2014, pp. 531–537.

[35]. Von Ruesten, A., Weikert, C., Fietze, I., et al., «Association of sleep duration with chronic diseases in the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam study», en PLoS ONE, 7(1), 2012, p. e30972.

[36]. Pan, A., De Silva, D. A., Yuan, J. M., et al., «Sleep duration and risk of stroke mortality among Chinese adults: Singapore Chinese health study», en Stroke, 45(6), 2014, pp. 1620–1625.

[37]. Leng, Y., Cappuccio, F. P., Wainwright, N. W., et al., «Sleep duration and risk of fatal and nonfatal stroke: a prospective study and meta-analysis», en Neurology, 84(11), 2015, pp. 1072–1079.

[38]. Sansevero, T. B., «The Profit Machine», Cultiva Libros, Madrid, 2009, p. 59.

[39]. Harman, D., «The biologic clock: the mitochondria?», en J Am Geriatr Soc., 20(4), 1972, pp. 145–147.

[40]. Chance, B., Sies, H., Boveris, A., «Hydroperoxide metabolism in mammalian organs», en Physiol Rev., 59(3), 1979, pp. 527–605.

[41]. Emerit, I., «Reactive oxygen species, chromosome mutation, and cancer: possible role of clastogenic factors in carcinogenesis», en Free Radic Biol Med., 16(1), 1994, pp. 99–109.

[42]. Rautiainen, S., Larsson, S., Virtamo, J., et al., «Total antioxidant capacity of diet and risk of stroke: a population-based prospective cohort of women», en Stroke, 43(2), 2012, pp. 335–340.

[43]. Del Rio, D., Agnoli, C., Pellegrini, N., et al., «Total antioxidant capacity of the diet is associated with lower risk of ischemic stroke in a large Italian cohort», en J Nutr., 141(1), 2011, pp. 118–123.

[44]. Satia, J. A., Littman, A., Slatore, C. G., Galanko, J. A., White, E., «Long-term use of beta-carotene, retinol, lycopene, and lutein supplements and lung cancer risk: results from the VITamins And Lifestyle (VITAL) study», en Am J Epidemiol., 169(7), 2009, pp. 815–828.

[45]. Hankey, G. J., «Vitamin supplementation and stroke prevention», en Stroke, 43(10), 2012, pp. 2814–2818.

[46]. Carlsen, M. H., Halvorsen, B. L., Holte, K., et al., «The total antioxidant content of more than 3100 foods, beverages, spices, herbs and supplements used worldwide», en Nutr J., 9, 22 de enero de 2010, p. 3.

[47]. Yang, M., Chung, S. J., Chung, C. E., et al., «Estimation of total antioxidant capacity from diet and supplements in US adults», en Br J Nutr., 106(2), 2011, pp. 254–263.

[48]. Carlsen, M. H., Halvorsen, B. L., Holte, K., et al., «The total antioxidant content of more than 3100 foods, beverages, spices, herbs and supplements used worldwide», en Nutr J., 9, 22 de enero de 2010, p. 3.

[49]. Bastin, S., Henken, K., «Water Content of Fruits and Vegetables, ENRI-129», University of Kentucky College of Agriculture Cooperative Extension Service, en <http://www2.ca.uky.edu/enri/pubs/enri129.pdf>, diciembre de 1997. Último acceso 3 de marzo de 2015.

*. Siglas en inglés de «capacidad de reducción férrica del plasma». (N. de la t.)

[50]. Carlsen, M. H., Halvorsen, B. L., Holte, K., et al., «The total antioxidant content of more than 3100 foods, beverages, spices, herbs and supplements used worldwide», en Nutr J., 9, 22 de enero de 2010, p. 3.

[51]. Carlsen, M. H., Halvorsen, B. L., Holte, K., et al., «The total antioxidant content of more than 3100 foods, beverages, spices, herbs and supplements used worldwide», en Nutr J., 9, 22 de enero de 2010, p. 3.

[52]. Kelly, P. J., Morrow, J. D., Ning, M., et al., «Oxidative stress and matrix metalloproteinase-9 in acute ischemic stroke: the Biomarker Evaluation for Antioxidant Therapies in Stroke (BEAT-Stroke) study», en Stroke, 39(1), 2008, pp. 100–104.

[53]. Lilamand, M., Kelaiditi, E., Guyonnet, S., et al., «Flavonoids and arterial stiff ness: promising perspectives», en Nutr Metab Cardiovasc Dis., 24(7), 2014, pp. 698–704.

[54]. Santhakumar, A. B., Bulmer, A. C., Singh, I., «A review of the mechanisms and effectiveness of dietary polyphenols in reducing oxidative stress and thrombotic risk», en J Hum Nutr Diet., 27(1), 2014, pp. 1–21.

[55]. Stoclet, J. C., Chataigneau, T., Ndiaye, M., et al., «Vascular protection by dietary polyphenols», en Eur J Pharmacol., 500(1–3), 2004, pp. 299–313.

[56]. Moylan, S., Berk, M., Dean, O. M., et al., «Oxidative & nitrosative stress in depression: why so much stress?», en Neurosci Biobehav Rev., 45, 2014, pp. 46–62.

[57]. Watzl, B., «Anti-inflammatory effects of plant-based foods and of their constituents», en Int J Vitam Nutr Res., 78(6), 2008, pp. 293–298.

[58]. Franzini, L., Ardigi, D., Valtuena, S., et al., «Food selection based on high total antioxidant capacity improves endothelial function in a low cardiovascular risk population», en Nutr Metab Cardiovasc Dis., 22(1), 2012, pp. 50–57.

[59]. «Alzheimer’s Association factsheet», en <http://www.alz.org/documents custom/2013_facts_figures_fact_sheet.pdf>, marzo de 2013. Último acceso 3 de abril de 2015.

[60]. De la Torre, J. C., «A turning point for Alzheimer’s disease?», en Biofactors, 38(2), 2012, pp. 78–83.

[61]. De la Torre, J. C., «Alzheimer’s disease is incurable but preventable», en J Alzheimers Dis., 20(3), 2010, pp. 861–870.

[62]. Barnes, D. E., Yaffe, K., «The projected effect of risk factor reduction on Alzheimer’s disease prevalence», en Lancet Neurol., 10(9), 2011, pp. 819–828.

[63]. Singh-Manoux, A., Kivimaki, M., Glymour, M. M., et al., «Timing of onset of cognitive decline: results from Whitehall II prospective cohort study», en BMJ, 344, 2012, p. d7622.

[64]. Roher, A. E., Tyas, S. L., Maarouf, C. L., et al., «Intracranial atherosclerosis as a contributing factor to Alzheimer’s disease dementia», en Alzheimers Dement., 7(4), 2011, pp. 436–444.

[65]. Barnard, N. D., Bush, A. I., Ceccarelli, A., et al., «Dietary and lifestyle guidelines for the prevention of Alzheimer’s disease», en Neurobiol Aging, 35 Suppl 2, 2014, pp. S74–S78.

[66]. Ramirez-Bermudez, J., «Alzheimer’s disease: critical notes on the history of a medical concept», Arch Med Res., 43(8), 2012, pp. 595–599.

[67]. Alzheimer, A., Stelzmann, R. A., Schnitzlein, H. N., Murtagh, F. R., traducción al inglés del artículo de Alzheimer’s de 1907: «Uber eine eigenartige Erkankung der Hirnrinde», en Clin Anat., 8(6), 1995, pp. 429–431.

[68]. Kovacic, J. C., Fuster, V., «Atherosclerotic risk factors, vascular cognitive impairment, and Alzheimer disease», en Mt Sinai J Med., 79, 2012, pp. 664–673.

[69]. «Cardiogenic Dementia», en Lancet, 1(8001), 1977, pp. 27–28.

[70]. Roher, A. E., Tyas, S. L., Maarouf, C. L., et al., «Intracranial atherosclerosis as a contributing factor to Alzheimer’s disease dementia», en Alzheimers Dement., 7(4), 2011, pp. 436–444.

[71]. Roher, A. E., Tyas, S. L., Maarouf, C. L., et al., «Intracranial atherosclerosis as a contributing factor to Alzheimer’s disease dementia», en Alzheimers Dement., 7(4), 2011, pp. 436–444.

[72]. Yarchoan, M., Xie, S. X., Kling, M. A., et al., «Cerebrovascular atherosclerosis correlates with Alzheimer pathology in neurodegenerative dementias», en Brain, 135(Pt 12), 2012, pp. 3749–3756.

[73]. Honig, L. S., Kukull, W., Mayeux, R., «Atherosclerosis and AD: analysis of data from the US National Alzheimer’s Coordinating Center», en Neurology, 64(3), 2005, pp. 494–500.

[74]. De la Torre, J. C., «Vascular risk factors: a ticking time bomb to Alzheimer’s disease», en Am J Alzheimers Dis Other Demen., 28(6), 2013, pp. 551–559.

[75]. Roher, A. E., Tyas, S. L., Maarouf, C. L., et al., «Intracranial atherosclerosis as a contributing factor to Alzheimer’s disease dementia», en Alzheimers Dement., 7(4), 2011, pp. 436–444.

[76]. De la Torre, J. C., «Vascular basis of Alzheimer’s pathogenesis», en Ann N Y Acad Sci., 977, 2002, pp. 196–215.

[77]. Zhu, J., Wang, Y., Li, J., et al., «Intracranial artery stenosis and progression from mild cognitive impairment to Alzheimer disease», en Neurology, 82(10), 2014, pp. 842–849.

[78]. Deschaintre, Y., Richard, F., Leys, D., Pasquier, F., «Treatment of vascular risk factors is associated with slower decline in Alzheimer disease», en Neurology, 73(9), 2009, pp. 674–680.

[79]. Mizuno, T., Nakata, M., Naiki, H., et al., «Cholesterol-dependent generation of a seeding amyloid beta-protein in cell culture», en J Biol Chem., 274(21), 1999, pp. 15110–15114.

[80]. Trumbo, P. R., Shimakawa, T., «Tolerable upper intake levels for trans fat, saturated fat, and cholesterol», en Nutr Rev., 69(5), 2011, pp. 270–278.

[81]. Benjamin, M. M., Roberts, W. C., «Facts and principles learned at the 39th Annual Williamsburg Conference on Heart Disease», en Proc (Bayl Univ Med Cent), 26(2), 2013, pp. 124–136.

[82]. Corsinovi, L., Biasi, F., Poli, G., et al., «Dietary lipids and their oxidized products in Alzheimer’s disease», en Mol Nutr Food Res., 55 Suppl 2, 2011, pp. S161–172.

[83]. Harris, J. R., Milton, N. G. N., «Cholesterol in Alzheimer’s disease and other amyloidogenic disorders», en Subcell Biochem., 51, 2010, pp. 47–75.

[84]. Puglielli, L., Tanzi, R. E., Kovacs, D. M., «Alzheimer’s disease: the cholesterol connection», en Nat Neurosci., 6(4), 2003, pp. 345–351.

[85]. Harris, J. R., Milton, N. G. N., «Cholesterol in Alzheimer’s disease and other amyloidogenic disorders», en Subcell Biochem., 51, 2010, pp. 47–75.

[86]. Reed, B., Villeneuve, S., Mack, W., et al., «Associations between serum cholesterol levels and cerebral amyloidosis», en JAMA Neurol., 71(2), 2014, pp. 195–200.

[87]. US Food and Drug Administration, «Important safety label changes to cholesterol-lowering statin drugs», US Department of Health and Human Services, Silver Spring, MD, 2012, en <http://www.fda.gov/Drugs/DrugSafety/ucm293101.htm>, 7 de julio de 2012. Último acceso 2 de abril de 2015.

[88]. Rojas-Fernandez, C. H., Cameron, J. C., «Is statin-associated cognitive impairment clinically relevant? A narrative review and clinical recommendations», en Ann Pharmacother., 46(4), 2012, pp. 549–557.

[89]. Grant, W. B., «Dietary links to Alzheimer’s disease», en Alzheimer Dis Rev., 2, 1997, pp. 42–55.

[90]. Chandra, V., Pandav, R., Dodge, H. H., et al., «Incidence of Alzheimer’s disease in a rural community in India: the Indo-US study», en Neurology, 57(6), 2001, pp. 985–989.

[91]. White, L., Petrovitch, H., Ross, G. W., et al., «Prevalence of dementia in older Japanese-American men in Hawaii: The Honolulu-Asia aging study», en JAMA, 276(12), 1996, pp. 955–960.

[92]. Grant, W. B., «Dietary links to Alzheimer’s disease», en Alzheimer Dis Rev., 2, 1997, pp. 42–55.

[93]. Grant, W. B., «Trends in diet and Alzheimer’s disease during the nutrition transition in Japan and developing countries», en J Alzheimers Dis., 38(3), 2014, pp. 611–620.

[94]. Chan, K. Y., Wang, W., Wu, J. J., et al., «Epidemiology of Alzheimer’s disease and other forms of dementia in China, 1990-2010: A systematic review and analysis», en Lancet, 381(9882), 2013, pp. 2016–2023.

[95]. Grant, W. B., «Trends in diet and Alzheimer’s disease during the nutrition transition in Japan and developing countries», en J Alzheimers Dis., 38(3), 2014, pp. 611–620.

[96]. Chandra, V., Ganguli, M., Pandav, R., et al., «Prevalence of Alzheimer’s disease and other dementias in rural India: the Indo-US study», en Neurology, 51(4), 1998, pp. 1000–1008.

[97]. Shetty, P. S., «Nutrition transition in India», en Public Health Nutr., 5(1A), 2002, pp. 175–182.

[98]. Giem, P., Beeson, W. L., Fraser, G. E., «The incidence of dementia and intake of animal products: preliminary findings from the Adventist Health Study», en Neuroepidemiology, 12(1), 1993, pp. 28–36.

[99]. Roses, A. D., Saunders, A. M., «APOE is a major susceptibility gene for Alzheimer’s disease», en Curr Opin Biotechnol., 5(6), 1994, pp. 663–667.

[100]. Puglielli, L., Tanzi, R. E., Kovacs, D. M., «Alzheimer’s disease: the cholesterol connection», en Nat Neurosci. 6(4), 2003, pp. 345–351.

[101]. Chen, X., Hui, L., Soliman, M. L., Geiger, J. D., «Altered cholesterol intracellular trafficking and the development of pathological hallmarks of sporadic AD», en J Parkinsons Dis Alzheimers Dis., 1(1), 2014.

[102]. Sepehrnia, B., Kamboh, M. I., Adams-Campbell, L. L., et al., «Genetic studies of human apolipoproteins.X. The effect of the apolipoprotein E polymorphism on quantitative levels of lipoproteins in Nigerian blacks», en Am J Hum Genet., 45(4), 1989, pp. 586–591.

[103]. Grant, W. B., «Dietary links to Alzheimer’s disease», en Alzheimer Dis Rev., 2, 1997, pp. 42–55.

[104]. Sepehrnia, B., Kamboh, M. I., Adams-Campbell, L. L., et al., «Genetic studies of human apolipoproteins.X. The effect of the apolipoprotein E polymorphism on quantitative levels of lipoproteins in Nigerian blacks», en Am J Hum Genet., 45(4), 1989, pp. 586–591.

[105]. Hendrie, H. C., Murrell, J., Gao, S., Unverzagt, F. W., Ogunniyi, A., Hall, K. S., «International studies in dementia with particular emphasis on populations of African origin», en Alzheimer Dis Assoc Disord., 20(3 Suppl 2), 2006, pp. S42–S46.

[106]. Kivipelto, M., Helkala, E. L., Laakso, M. P., et al., «Apolipoprotein E epsilon4 allele, elevated midlife total cholesterol level, and high midlife systolic blood pressure are in de pen dent risk factors for late-life Alzheimer disease», en Ann Intern Med., 137(3), 2002, pp. 149–155.

[107]. Kivipelto, M., Helkala, E. L., Laakso, M. P., et al., «Apolipoprotein E epsilon4 allele, elevated midlife total cholesterol level, and high midlife systolic blood pressure are in de pen dent risk factors for late-life Alzheimer disease», en Ann Intern Med., 137(3), 2002, pp. 149–155.

[108]. Jost, B. C., Grossberg, G. T., «The natural history of Alzheimer’s disease: a brain bank study», en J Am Geriatr Soc., 43(11), 1995, pp. 1248–1255.

[109]. Del Tredici, K., Braak, H., «Neurofibrillary changes of the Alzheimer type in very elderly individuals: neither inevitable nor benign: Commentary on ‘No disease in the brain of a 115-year-old woman’», en Neurobiol Aging, 29(8), 2008, pp. 1133–1136.

[110]. Barnard, N. D., Bush, A. I., Ceccarelli, A., et al., «Dietary and lifestyle guidelines for the prevention of Alzheimer’s disease», en Neurobiol Aging, 35 Suppl 2, 2014, pp. S74–S78.

[111]. Lourida, I., Soni, M., Thompson-Coon, J., et al., «Mediterranean diet, cognitive function, and dementia: a systematic review», en Epidemiology, 24(4), 2013, pp. 479–489.

[112]. Roberts, R. O., Geda, Y. E., Cerhan, J. R., et al., «Vegetables, unsaturated fats, moderate alcohol intake, and mild cognitive impairment», en Dementia and Geriatric Cognitive Disorders, 29(5), 2010, pp. 413–423.

[113]. Okereke, O. I., Rosner, B. A., Kim, D. H., et al., «Dietary fat types and 4-year cognitive change in community-dwelling older women», en Ann Neurol., 72(1), 2012, pp. 124–134.

[114]. Parletta, N., Milte, C. M., Meyer, B. J., «Nutritional modulation of cognitive function and mental health», en J Nutr Biochem., 24(5), 2013, pp. 725–743.

[115]. Essa, M. M., Vijayan, R. K., Castellano-González, G., Memon, M. A., Braidy, N., Guillemin, G. J., «Neuroprotective effect of natural products against Alzheimer’s disease», en Neurochem Res., 37(9), 2012, pp. 1829–1842.

[116]. Shukitt-Hale, B., «Blueberries and neuronal aging», en Gerontology, 58(6), 2012, pp. 518–523.

[117]. Cherniack, E. P., «A berry thought-provoking idea: the potential role of plant polyphenols in the treatment of age-related cognitive disorders», en Br J Nutr., 108(5), 2012, pp. 794–800.

[118]. Johnson, E. J., «A possible role for lutein and zeaxanthin in cognitive function in the elderly», en Am J Clin Nutr., 96(5), 2012, pp. 1161S-1165S.

[119]. Krikorian, R., Shidler, M. D., Nash, T. A., et al., «Blueberry supplementation improves memory in older adults», en J Agric Food Chem., 58(7), 2010, pp. 3996–4000.

[120]. Devore, E. E., Kang, J. H., Breteler, M. M. B., et al., «Dietary intakes of berries and flavonoids in relation to cognitive decline», en Ann Neurol, 72(1), 2012, pp. 135–143.

[121]. Dai, Q., Borenstein, A. R., Wu, Y., et al., «Fruit and vegetable juices and Alzheimer’s disease: the Kame Project», en Am J Med., 119(9), 2006, pp. 751–759.

[122]. Krikorian, R., Nash, T. A., Shidler, M. D., Shukitt-Hale, B., Joseph, J. A., «Concord grape juice supplementation improves memory function in older adults with mild cognitive impairment», en Br J Nutr., 103(5), 2010, pp. 730–734.

[123]. Nurk, E., Refsum, H., Drevon, C. A., et al., «Cognitive performance among the elderly in relation to the intake of plant foods. The Hordaland Health Study», en Br J Nutr., 104(8), 2010, pp. 1190–1201.

[124]. Mullen, W., Marks, S. C., Crozier, A., «Evaluation of phenolic compounds in commercial fruit juices and fruit drinks», en J Agric Food Chem., 55(8), 2007, pp. 3148–3157.

[125]. Tarozzi, A., Morroni, F., Merlicco, A., et al., «Neuroprotective effects of cyanidin 3-O-glucopyranoside on amyloid beta (25–35) oligomer-induced toxicity», en Neurosci Lett., 473(2), 2010, pp. 72–76.

[126]. Hattori, M., Sugino, E., Minoura, K., et al., «Different inhibitory response of cyanidin and methylene blue for filament formation of tau microtubule-binding domain», en Biochem Biophys Res Commun., 374(1), 2008, pp. 158–163.

[127]. Mandel, S. A., Weinreb, O., Amit, T., Youdim, M. B., «Molecular mechanisms of the neuroprotective/neurorescue action of multi-target green tea polyphenols», en Front Biosci (Schol Ed), 4, 2012, pp. 581–598.

[128]. Ward, R. J., Zucca, F. A., Duyn, J. H., Crichton, R. R., Zecca, L., «The role of iron in brain ageing and neurodegenerative disorders», en Lancet Neurol., 13(10), 2014, pp. 1045–1060.

[129]. Hishikawa, N., Takahashi, Y., Amakusa, Y., et al., «Effects of turmeric on Alzheimer’s disease with behavioral and psychological symptoms of dementia», en Ayu. 33(4), 2012, pp. 499–504.

[130]. Akhondzadeh, S., Sabet, M. S., Harirchian, M. H., et al., «Saffron in the treatment of patients with mild to moderate Alzheimer’s disease: a 16-week, randomized and placebo-controlled trial», en J Clin Pharm Ther., 35(5), 2010, pp. 581–588.

[131]. Akhondzadeh, S., Shafiee Sabet M., Harirchian, M. H., et al., «A 22-week, multicenter, randomized, double-blind controlled trial of Crocus sativus in the treatment of mild-to-moderate Alzheimer’s disease», en Psychopharmacology (Berl), 207(4), 2010, pp. 637–643.

[132]. Hyde, C., Peters, J., Bond, M., et al., «Evolution of the evidence on the effectiveness and cost-effectiveness of acetylcholinesterase inhibitors and memantine for Alzheimer’s disease: systematic review and economic model», en Age Ageing, 42(1), 2013, pp. 14–20.

[133]. US Food and Drug Administation, «ARICEPT® (Donepezil Hydrochloride Tablets) package insert», en <http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Surveillance/DrugMarketingAdvertisingandCommunications/UCM368444.pdf>. Último acceso 2 de abril de 2015.

[134]. Toledo, C., Saltsman, K., «Genetics by the Numbers. Inside Life Science», National Institute of General Medical Sciences, Bethesda, MD, en <http://publications.nigms.nih.gov/insidelifescience/genetics-numbers.html>, 11 de junio de 2012. Último acceso 3 de marzo de 2015.

[135]. Mostoslavsky, R., Esteller, M., Vaquero, A., «At the crossroad of lifespan, calorie restriction, chromatin and disease: meeting on sirtuins», en Cell Cycle, 9(10), 2010, pp. 1907–1912.

[136]. Julien, C., Tremblay, C., Emond, V., et al., «Sirtuin 1 reduction parallels the accumulation of tau in Alzheimer disease», en J Neuropathol Exp Neurol., 68(1), 2009, pp. 48–58.

[137]. Cai, W., Uribarri, J., Zhu, L., et al., «Oral glycotoxins are a modifiable cause of dementia and the metabolic syndrome in mice and humans», en Proc Natl Acad Sci USA, 111(13), 2014, pp. 4940–4945.

[138]. Cai, W., Uribarri, J., Zhu, L., et al., «Oral glycotoxins are a modifiable cause of dementia and the metabolic syndrome in mice and humans», en Proc Natl Acad Sci USA, 111(13), 2014, pp. 4940–4945.

[139]. Rahmadi, A., Steiner, N., Münch, G., «Advanced glycation endproducts as gerontotoxins and biomarkers for carbonyl-based degenerative processes in Alzheimer’s disease», en Clin Chem Lab Med., 49(3), 2011, pp. 385–391.

[140]. Semba, R. D., Nicklett, E. J., Ferrucci, L., «Does accumulation of advanced glycation end products contribute to the aging phenotype?», en J Gerontol A Biol Sci Med Sci., 65(9), 2010, pp. 963–975.

[141]. Srikanth, V., Westcott, B., Forbes, J., et al., «Methylglyoxal, cognitive function and cerebral atrophy in older people», en J Gerontol A Biol Sci Med Sci., 68(1), 2013, pp. 68–73.

[142]. Cai, W., Uribarri, J., Zhu, L., et al., «Oral glycotoxins are a modifiable cause of dementia and the metabolic syndrome in mice and humans», en Proc Natl Acad Sci USA, 111(13), 2014, pp. 4940–4945.

[143]. Beeri, M. S., Moshier, E., Schmeidler, J., et al., «Serum concentration of an inflammatory glycotoxin, methylglyoxal, is associated with increased cognitive decline in elderly individuals», en Mech Ageing Dev., 132(11–12), 2011, pp. 583–587.

[144]. Yaffe, K., Lindquist, K., Schwartz, A. V., et al., «Advanced glycation end product level, diabetes, and accelerated cognitive aging», en Neurology, 77(14), 2011, pp. 1351–1356.

[145]. Angeloni, C., Zambonin, L., Hrelia, S., «Role of methylglyoxal in Alzheimer’s disease», en Biomed Res Int., 2014, 2014, p. 238485.

[146]. Vlassara, H., Cai, W., Goodman, S., et al., «Protection against loss of innate defenses in adulthood by low advanced glycation end products (AGE) intake: role of the anti-inflammatory AGE receptor-1», en J Clin Endocrinol Metab., 94(11), 2009, pp. 4483–4491.

[147]. Cerami, C., Founds, H., Nicholl, I., et al., «Tobacco smoke is a source of toxic reactive glycation products», Proc Natl Acad Sci USA, 94(25), 1997, pp. 13915–13920.

[148]. Uribarri, J., Cai, W., Sandu, O., Peppa, M., Goldberg, T., Vlassara, H., «Diet-derived advanced glycation end products are major contributors to the body’s AGE pool and induce inflammation in healthy subjects», en Ann N Y Acad Sci., 1043, 2005, pp. 461–466.

[149]. Uribarri, J., Cai, W., Sandu, O., Peppa, M., Goldberg, T., Vlassara, H., «Diet-derived advanced glycation end products are major contributors to the body’s AGE pool and induce inflammation in healthy subjects», en Ann N Y Acad Sci., 1043, 2005, pp. 461–466.

[150]. Uribarri, J., Woodruff, S., Goodman, S., et al., «Advanced glycation end products in foods and a practical guide to their reduction in the diet», en J Am Diet Assoc., 110(6), 2010, pp. 911–916.e12.

[151]. Uribarri, J., Woodruff, S., Goodman, S., et al., «Advanced glycation end products in foods and a practical guide to their reduction in the diet», en J Am Diet Assoc., 110(6), 2010, pp. 911–916.e12.

[152]. Uribarri, J., Woodruff, S., Goodman, S., et al., «Advanced glycation end products in foods and a practical guide to their reduction in the diet», en J Am Diet Assoc., 110(6), 2010, pp. 911–916.e12.

[153]. Cai, W., Uribarri, J., Zhu, L., et al., «Oral glycotoxins are a modifiable cause of dementia and the metabolic syndrome in mice and humans», en Proc Natl Acad Sci USA, 111(13), 2014, pp. 4940–4945.

[154]. Baker, L. D., Frank, L. L., Foster-Schubert, K., et al., «Effects of aerobic exercise on mild cognitive impairment: a controlled trial», en Arch Neurol., 67(1), 2010, pp. 71–79.

[155]. Baker, L. D., Frank, L. L., Foster-Schubert, K., et al., «Effects of aerobic exercise on mild cognitive impairment: a controlled trial», en Arch Neurol., 67(1), 2010, pp. 71–79.

[156]. Erickson, K.I., Voss, M. W., Prakash, R. S., et al., «Exercise training increases size of hippocampus and improves memory», en Proc Natl Acad Sci USA, 108(7), 2011, pp. 3017–3022.

[157]. Ten Brinke, L. F., Bolandzadeh, N., Nagamatsu, L. S., et al., «Aerobic exercise increases hippocampal volume in older women with probable mild cognitive impairment: a 6-month randomised controlled trial», en Br J Sports Med., 49(4), 2015, pp. 248–254.

 

 

4. No morir de un cáncer del aparato digestivo

 

[1]. Liu, P. H., Wang, J. D., Keating, N. L., «Expected years of life lost for six potentially preventable cancers in the United States», en Prev Med., 56(5), 2013, pp. 309–313.

[2]. Bertram, J. S., Kolonel, L. N., Meyskens, F. L., «Rationale and strategies for chemoprevention of cancer in humans», en Cancer Res., 47(11), 1987, pp. 3012–3031.

[3]. Hasleton, P. S., «The internal surface area of the adult human lung», en J Anat., 112(Pt 3), 1972, pp. 391–400.

[4]. Macdonald, T. T., Monteleone, G., «Immunity, inflammation, and allergy in the gut», en Science, 307(5717), 2005, pp. 1920–1925.

[5]. «What are the key statistics about colorectal cancer?», en la página web de American Cancer Society, <http://www.cancer.org/cancer/colonandrectumcan cer/detailedguide/colorectal-cancer-key-statistics>. Último acceso 3 de marzo de 2015.

[6]. «What are the key statistics about pancreatic cancer?», en la página web de American Cancer Society, <http://www.cancer.org/cancer/pancreaticcancer/detai ledguide/pancreatic-cancer-key-statistics>. Último acceso 3 de marzo de 2015.

[7]. American Cancer Society, «Cancer Facts & Figures 2014», American Cancer Society, Atlanta, 2014.

[8]. «What are the key statistics about colorectal cancer?», en la página web de American Cancer Society, <http://www.cancer.org/cancer/colonandrectumcancer/detailedguide/colorectal-cancer-key-statistics>. Último acceso 3 de marzo de 2015.

[9]. American Cancer Society, «Cancer Facts & Figures 2014», American Cancer Society, Atlanta, 2014.

[10]. «Screening for Colorectal Cancer», en la página web de US Preventive Services Task Force, <http://www.uspreventiveservicestaskforce.org/Home/GetFi le/1/467/colcancsumm/pdf>. Último acceso 3 de marzo de 2015.

[11]. Fondo Monetario Internacional, «World Economic Outlook Database», en <http://bit.ly/1bNdlWu>, abril de 2012. Último acceso 2 de mayo de 2015.

[12]. Banco Mundial, «World Development Indicators», en <http://data.worldbank.org/country/india>, 2011. Último acceso 2 de mayo de 2015.

[13]. Bengmark, S., Mesa, M. D., Gill, A., «Plant-derived health: the effects of turmeric and curcuminoids», en Nutr Hosp., 24(3), 2009, pp. 273–281.

[14]. Hutchins-Wolfbrandt, A., Mistry, A. M., «Dietary turmeric potentially reduces the risk of cancer», en Asian Pac J Cancer Prev., 12(12), 2011, pp. 3169–3173.

[15]. Sharma, R. A., Euden, S. A., Platton, S. L., et al., «Phase I clinical trial of oral curcumin: biomarkers of systemic activity and compliance», en Clin Cancer Res., 10(20), 2004, pp. 6847–6854.

[16]. Carroll, R. E., Benya, R. V., Turgeon, D. K., et al., «Phase II a clinical trial of curcumin for the prevention of colorectal neoplasia», en Cancer Prev Res. (Filadelfia), 4(3), 2011, pp. 354–364.

[17]. Cruz-Correa, M., Shoskes, D. A., Sanchez, P., et al., «Combination treatment with curcumin and quercetin of adenomas in familial adenomatous polyposis», en Clin Gastroenterol Hepatol., 4(8), 2006, pp. 1035–1038.

[18]. Sharma, R. A., McLelland, H. R., Hill, K. A., et al., «Pharmacodynamic and pharmacokinetic study of oral Curcuma extract in patients with colorectal cancer», en Clin Cancer Res., 7(7), 2001, pp. 1894–1900.

[19]. Singh, S., «From exotic spice to modern drug?», en Cell, 130(5), 2007, pp. 765–758.

[20]. International Institute for Population Sciences & Macro International, National Family Health Survey (NFHS-3), India, 2005–2006, vol. I., IIPS, Bombay, 2007.

[21]. Cummings, J. H., Bingham, S. A., Heaton, K. W., Eastwood, M. A., «Fecal weight, colon cancer risk, and dietary intake of non-starch polysaccharides (dietary fiber)», en Gastroenterology, 103(6), 1992, pp. 1783–1789.

[22]. Gear, J. S., Brodribb, A. J., Ware, A., Mann, J. I., «Fibre and bowel transit times», en Br J Nutr., 45(1), 1981, pp. 77–82.

[23]. Burkitt, D. P., Walker, A. R., Painter, N. S., «Effect of dietary fibre on stools and the transit-times, and its role in the causation of disease», en Lancet, 2(7792), 1972, pp. 1408–1412.

[24]. Sonnenberg, A., Koch, T. R., «Physician visits in the United States for constipation: 1958 to 1986», en Dig Dis Sci., 34(4), 1989, pp. 606–611.

[25]. Burkitt, D. P., «A deficiency of dietary fiber may be one cause of certain colonic and venous disorders», en Am J Dig Dis., 21(2), 1976, pp. 104–108.

[26]. Fox, A., Tietze, P. H., Ramakrishnan, K., «Anorectal conditions: anal fissure and anorectal fistula», en FP Essent., 419, 2014, pp. 20–27.

[27]. Burkitt, D. P., «A deficiency of dietary fiber may be one cause of certain colonic and venous disorders», en Am J Dig Dis., 21(2), 1976, pp. 104–108.

[28]. Sanjoaquin, M. A., Appleby, P. N., Spencer, E. A., Key, T. J., «Nutrition and lifestyle in relation to bowel movement frequency: a cross-sectional study of 20630 men and women in EPIC-Oxford», en Public Health Nutr., 7(1), 2004, pp. 77–83.

[29]. «What are the key statistics about colorectal cancer?», en la página web de American Cancer Society, <http://www.cancer.org/cancer/colonandrectumcancer/detailedguide/colorectal-cancer-key-statistics>. Último acceso 3 de marzo de 2015.

[30]. Doll, R., «The geographical distribution of cancer», en Br J Cancer, 23(1), 1969, pp. 1–8.

[31]. Lipski, E., «Traditional non-Western diets», en Nutr Clin Pract., 25(6), 2010, pp. 585–593.

[32]. Burkitt, D. P., «Epidemiology of cancer of the colon and rectum: 1971», en Dis. Colon Rectum, 36(11), 1993, pp. 1071–1082.

[33]. Shaper, A. G., Jones, K. W., «Serum-cholesterol, diet, and coronary heart-disease in Africans and Asians in Uganda: 1959», en Int J Epidemiol., 41(5), 2012, pp. 1221–1225.

[34]. Malila, N., Hakulinen, T., «Epidemiological trends of colorectal cancer in the Nordic countries», en Scand J Surg., 92(1), 2003, pp. 5–9.

[35]. Englyst, H. N., Bingham, S. A., Wiggins, H. S., et al., «Nonstarch polysaccharide consumption in four Scandinavian populations», en Nutr Cancer, 4(1), 1982, pp. 50–60.

[36]. Graf, E., Eaton, J. W., «Dietary suppression of colonic cancer. Fiber or phytate?», en Cancer, 56(4), 1985, pp. 717–718.

[37]. Fonseca-Nunes, A., Jakszyn, P., Agudo, A., «Iron and cancer risk—a systematic review and metaanalysis of the epidemiological evidence», en Cancer Epidemiol Biomarkers Prev., 23(1), 2014, pp. 12–31.

[38]. Mellanby, E., «The rickets-producing and anti-calcifying action of phytate», en J Physiol., 109(3–4), 1949, pp. 488–533.

[39]. House, W. A., Welch, R. M., Van Campen, D. R., «Effect of phytic acid on the absorption, distribution, and endogenous excretion of zinc in rats», en J Nutr., 112(5), 1982, pp. 941–953.

[40]. Urbano, G., López-Jurado, M., Aranda, P., Vidal Valverde, C., Tenorio, E., Porres, J., «The role of phytic acid in legumes: anti-nutrient or beneficial function?», en J Physiol Biochem., 56(3), 2000, pp. 283–294.

[41]. López-González, A. A., Grases, F., Roca, P., Mari, B., Vicente Herrero, M. T., Costa Bauza, A., «Phytate (myo-inositol hexaphosphate) and risk factors for osteoporosis», en J Med Food, 11(4), pp. 747–752.

[42]. López-González, A. A., Grases, F., Monroy, N., et al., «Protective effect of myo-inositol hexaphosphate (phytate) on bone mass loss in postmenopausal women», en Eur J Nutr., 52(2), 2013, pp. 717–726.

[43]. Arriero, M. del M., Ramis, J. M., Perelló, J., Monjo, M., «Inositol hexakisphosphate inhibits osteoclastogenesis on RAW 264.7 cells and human primary osteoclasts», en PLoS ONE, 7(8), 2012, p. e43187.

[44]. Khosla, S., Burr, D., Cauley, J., et al., «Bisphosphonate-associated osteonecrosis of the jaw: report of a task force of the American Society for Bone and Mineral Research», en J Bone Miner Res., 22(10), 2007, pp. 1479–1491.

[45]. Singh, P. N., Fraser, G. E., «Dietary risk factors for colon cancer in a low-risk population», en Am J Epidemiol., 148(8), 1998, pp. 761–774.

[46]. Manousos, O., Day, N. E., Trichopoulos, D., Gerovassilis, F., Tzonou, A., Polychronopoulou, A., «Diet and colorectal cancer: A case-control study in Greece», en Int J Cancer, 32(1), 1983, pp. 1–5.

[47]. Lanza, E., Hartman, T. J., Albert, P. S., et al., «High dry bean intake and reduced risk of advanced colorectal adenoma recurrence among participants in the polyp prevention trial», en J Nutr., 136(7), 2006, pp. 1896–1903.

[48]. Vucenik, I., Shamsuddin, A. M., «Protection against cancer by dietary IP6 and inositol», en Nutr Cancer, 55(2), 2006, pp. 109–125.

[49]. Vucenik, I., Shamsuddin, A. M., «Cancer inhibition by inositol hexaphosphate (IP6) and inositol: from laboratory to clinic», en J Nutr., 133(11–Suppl-1), 2003, pp. 3778S-3784S.

[50]. Ogawa, S., Kobayashi, H., Amada, S., et al., «Sentinel node detection with (99m)Tc phytate alone is satisfactory for cervical cancer patients undergoing radical hysterectomy and pelvic lymphadenectomy», en Int J Clin Oncol., 15(1), 2010, pp. 52–58.

[51]. Vucenik, I., Shamsuddin, A. M., «Protection against cancer by dietary IP6 and inositol», en Nutr Cancer, 55(2), 2006, pp. 109–125.

[52]. Vucenik, I., Passaniti, A., Vitolo, M. I., Tantivejkul, K., Eggleton, P., Shamsuddin, A. M., «Anti-angiogenic activity of inositol hexaphosphate (IP6)», en Carcinogenesis, 25(11), 2004, pp. 2115–2123.

[53]. Wang, H., Khor, T. O., Shu, L., et al., «Plants vs. cancer: a review on natural phytochemicals in preventing and treating cancers and their druggability», en Anticancer Agents Med Chem., 12(10), 2012, pp. 1281–1305.

[54]. Yang, G. Y., Shamsuddin, A. M., «IP6-induced growth inhibition and differentiation of HT-29 human colon cancer cells: involvement of intracellular inositol phosphates», en Anticancer Res., 15 (6B), 1995, pp. 2479–2487.

[55]. Shamsuddin, A. M., Yang, G. Y., Vucenik, I., «Novel anti-cancer functions of IP6: growth inhibition and differentiation of human mammary cancer cell lines in vitro», en Anticancer Res., 16(6A), 1996, pp. 3287–3292.

[56]. Vucenik, I., Tantivejkul, K., Zhang, Z. S., Cole, K. E., Saied, I., Shamsuddin, A. M., «IP6 in treatment of liver cancer. I. IP6 inhibits growth and reverses transformed phenotype in HepG2 human liver cancer cell line», en Anticancer Res., 18(6A), 1998, pp. 4083–4090.

[57]. Shamsuddin, A. M., Yang, G. Y., «Inositol hexaphosphate inhibits growth and induces differentiation of PC-3 human prostate cancer cells», en Carcinogenesis, 16(8), 1995, pp. 1975–1979.

[58]. Shamsuddin, A. M., «Anti-cancer function of phytic acid», en Int J Food Sci Tech., 37(7), 2002, pp. 769–782.

[59]. Sun, J., Chu, Y. F., Wu, X., Liu, R. H., «Antioxidant and antiproliferative activities of common fruits», en J Agric Food Chem., 50(25), 2002, pp. 7449–7454.

[60]. Olsson, M. E., Andersson, C. S., Oredsson, S., Berglund, R. H., Gustavsson, K. E., «Antioxidant levels and inhibition of cancer cell proliferation in vitro by extracts from organically and conventionally cultivated strawberries», en J Agric Food Chem., 54(4), 2006, pp. 1248–1255.

[61]. Graham, D. J., Campen, D., Hui, R., et al., «Risk of acute myocardial infarction and sudden cardiac death in patients treated with cyclo-oxygenase 2 selective and non-selective non-steroidal anti-inflammatory drugs: nested case-control study», en Lancet, 365(9458), 2005, pp. 475–481.

[62]. Wang, L. S., Burke, C. A., Hasson, H., et al., «A phase Ib study of the effects of black raspberries on rectal polyps in patients with familial adenomatous polyposis», en Cancer Prev Res. (Filadelfia), 7(7), 2014, pp. 666–674.

[63]. Wang, L. S., Burke, C. A., Hasson, H., et al., «A phase Ib study of the effects of black raspberries on rectal polyps in patients with familial adenomatous polyposis», en Cancer Prev Res. (Filadelfia), 7(7), 2014, pp. 666–674.

[64]. Pan, A., Sun, Q., Bernstein, A. M., et al., «Red meat consumption and mortality: Results from 2 prospective cohort studies», en Arch Intern Med., 172(7), 2012, pp. 555–563.

[65]. Sinha, R., Cross, A. J., Graubard, B. I., Leitzmann, M. F., Schatzkin, A., «Meat intake and mortality: a prospective study of over half a million people», en Arch Intern Med., 169(6), 2009, pp. 562–571.

[66]. Popkin, B. M., «Reducing meat consumption has multiple benefits for the world’s health», en Arch Intern Med., 169(6), 2009, pp. 543.

[67]. Dixon, S. J., Stockwell, B. R., «The role of iron and reactive oxygen species in cell death», en Nat Chem Biol., 10(1), 2014, pp. 9–17.

[68]. Hurrell, R., Egli, I., «Iron bioavailability and dietary reference values», en Am J Clin Nutr., 91(5), 2010, pp. 1461S-1467S.

[69]. Cook, J. D., «Adaptation in iron metabolism», en Am J Clin Nutr., 51(2), 1990, pp. 301–308.

[70]. Fonseca Nunes, A., Jakszyn, P., Agudo, A., «Iron and cancer risk—a systematic review and meta-analysis of the epidemiological evidence», en Cancer Epidemiol Biomarkers Prev., 23(1), 2014, pp. 12–31.

[71]. Yang, W., Li, B., Dong, X., et al., «Is heme iron intake associated with risk of coronary heart disease? A meta-analysis of prospective studies», en Eur J Nutr., 53(2), 2014, pp. 395–400.

[72]. Bao, W., Rong, Y., Rong, S., Liu, L., «Dietary iron intake, body iron stores, and the risk of type 2 diabetes: a systematic review and meta-analysis», en BMC Med., 10, 2012, p. 119.

[73]. Zacharski, L. R., Chow, B. K., Howes, P. S., et al., «Decreased cancer risk after iron reduction in patients with peripheral arterial disease: results from a randomized trial», en J Natl Cancer Inst., 100(14), 2008, pp. 996–1002.

[74]. Edgren, G., Nyrén, O., Melbye, M., «Cancer as a ferrotoxic disease: are we getting hard stainless evidence?», en J Natl Cancer Inst., 100(14), 2008, pp. 976–977.

[75]. Corpet, D. E., «Red meat and colon cancer: should we become vegetarians, or can we make meat safer?», en Meat Sci., 89(3), 2011, pp. 310–316.

[76]. Farmer, B., Larson, B. T., Fulgoni, V. L. 3rd, Rainville, A. J., Liepa, G. U., «A vegetarian dietary pattern as a nutrient-dense approach to weight management: an analysis of the national health and nutrition examination survey 1999–2004», en J Am Diet Assoc., 111(6), 2011, pp. 819–827.

[77]. «Iron deficiency—United States, 1999–2000», en MMWR Morb Mortal Wkly Rep., 51(40), 2002, pp. 897–899.

[78]. Craig, W. J., Mangels, A. R., «Position of the American Dietetic Association: vegetarian diets», en J Am Diet Assoc., 109(7), 2009, pp. 1266–1282.

[79]. Tiwari, A. K., Mahdi, A. A., Chandyan, S., et al., «Oral iron supplementation leads to oxidative imbalance in anemic women: a prospective study», en Clin Nutr., 30(2), 2011, pp. 188–193.

[80]. Saunders, A. V., Craig, W. J., Baines, S. K., Posen, J. S., «Iron and vegetarian diets», en Med J Aust., 199(4-Suppl), 2013, pp. S11–S16.

[81]. «American Cancer Society. Cancer Facts & Figures 2014», American Cancer Society, Atlanta, 2014.

[82]. Iodice, S., Gandini, S., Maisonneuve, P., Lowenfels, A. B., «Tobacco and the risk of pancreatic cancer: a review and meta-analysis», en Langenbecks Arch Surg., 393(4), 2008, pp. 535–545.

[83]. Kolodecik, T., Shugrue, C., Ashat, M., Thrower, E. C., «Risk factors for pancreatic cancer: underlying mechanisms and potential targets», en Front Physiol., 4:415, 2013.

[84]. Thiebaut, A. C., Jiao, L., Silverman, D. T., et al., «Dietary fatty acids and pancreatic cancer in the NIHAARP diet and health study», en J Natl Cancer Inst., 101(14), 2009, pp. 1001–1011.

[85]. Landrigan, P. J., «Preface», en Ann N Y Acad Sci., 643, 1991, pp. xv–xvi.

[86]. Weiner, R., Rees, D., Lunga, F. J., Felix, M. A., «Third wave of asbestos-related disease from secondary use of asbestos. A case report from industry», en S Afr Med J., 84(3), 1994, pp. 158–160.

[87]. Johnson, E. S., Zhou, Y., Lillian Yau, C., et al., «Mortality from malignant diseases-update of the Baltimore union poultry cohort» en Cancer Causes Control, 21(2), 2010, pp. 215–221.

[88]. Felini, M., Johnson, E., Preacely, N., Sarda, V., Ndetan, H., Bangara, S., «A pilot case-cohort study of liver and pancreatic cancers in poultry workers», en Ann Epidemiol., 21(10), 2011, pp. 755–766.

[89]. Lynch, S. M., Vrieling, A., Lubin, J. H., et al., «Cigarette smoking and pancreatic cancer: a pooled analysis from the pancreatic cancer cohort consortium», en Am J Epidemiol., 170(4), 2009, pp. 403–413.

[90]. Rohrmann, S., Linseisen, J., Nothlings, U., et al., «Meat and fish consumption and risk of pancreatic cancer: results from the European Prospective Investigation into Cancer and Nutrition», en Int J Cancer, 132(3), 2013, pp. 617–624.

[91]. Rohrmann, S., Linseisen, J., Jakobsen, M. U., et al., «Consumption of meat and dairy and lymphoma risk in the European Prospective Investigation into Cancer and Nutrition», en Int J Cancer, 128(3), 2011, pp. 623–634.

[92]. Lotti, M., Bergamo, L., Murer, B., «Occupational toxicology of asbestos-related malignancies», en Clin Toxicol. (Filadelfia), 48(6), 2010, pp. 485–496.

[93]. Marvisi, M., Balzarini, L., Mancini, C., Mouzakiti, P., «A new type of hypersensitivity pneumonitis: salami brusher’s disease», en Monaldi Arch Chest Dis., 77(1), 2012, pp. 35–37.

[94]. Yang, Z. Y., Yuan, J. Q., Di, M. Y., et al., «Gemcitabine plus erlotinib for advanced pancreatic cancer: a systematic review with meta-analysis», en PLoS ONE, 8(3), 2013, p. e57528.

[95]. Li, L., Aggarwal, B. B., Shishodia, S., Abbruzzese, J., Kurzrock, R., «Nuclear factor-kappaB and IkappaB kinase are constitutively active in human pancreatic cells, and their down-regulation by curcumin (diferuloylmethane) is associated with the suppression of proliferation and the induction of apoptosis», en Cancer, 101(10), 2004, pp. 2351–2362.

[96]. Dhillon, N., Aggarwal, B. B., Newman, R. A., et al., «Phase II trial of curcumin in patients with advanced pancreatic cancer», en Clin Cancer Res., 14(14), 2008, pp. 4491–4499.

[97]. Bosetti, C., Bravi, F., Turati, F., et al., «Nutrient-based dietary patterns and pancreatic cancer risk», en Ann Epidemiol., 23(3), 2013, pp. 124–128.

[98]. Mills, P. K., Beeson, W. L., Abbey, D. E., Fraser, G. E., Phillips, R. L., «Dietary habits and past medical history as related to fatal pancreas cancer risk among Adventists», en Cancer, 61(12), 1988, pp. 2578–2585.

[99]. «American Cancer Society. Cancer Facts & Figures 2014», American Cancer Society, Atlanta, 2014.

[100]. Bagnardi, V., Rota, M., Botteri, E., et al., «Light alcohol drinking and cancer: a meta-analysis», en Ann Oncol., 24(2), 2013, pp. 301–308.

[101]. Rubenstein, J. H., Chen, J. W., «Epidemiology of gastroesophageal reflux disease», en Gastroenterol Clin North Am., 43(1), 2014, pp. 1–14.

[102]. Lagergren, J., Bergstrom, R., Lindgren, A., Nyren, O., «Symptomatic gastro-esophageal reflux as a risk factor for esophageal adenocarcinoma», en N Engl J Med., 340(11), 1999, pp. 825–831.

[103]. Pohl, H., Welch, H. G., «The role of over-diagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence», en J Natl Cancer Inst., 97(2), 2005, pp. 142–146.

[104]. Parasa, S., Sharma, P., «Complications of gastrooesophageal reflux disease», en Best Pract Res Clin Gastroenterol., 27(3), 2013, pp. 433–442.

[105]. El-Serag, H. B., «Time trends of gastroesophageal reflux disease: a systematic review», en Clin Gastroenterol Hepatol., 5(1), 2007, pp. 17–26.

[106]. De Ceglie, A., Fisher, D. A., Filiberti, R., Blanchi, S., Conio, M., «Barrett’s esophagus, esophageal and esophagogastric junction adenocarcinomas: the role of diet», en Clin Res Hepatol Gastroenterol., 35(1), 2011, pp. 7–16.

[107]. Navarro Silvera, S. A., Mayne, S. T., Risch, H., et al., «Food group intake and risk of subtypes of esophageal and gastric cancer», en Int J Cancer, 123(4), 2008, pp. 852–860.

[108]. Nebel, O. T., Castell, D. O., «Lower esophageal sphincter pressure changes after food ingestion», en Gastroenterology, 63(5), 1972, pp. 778–783.

[109]. Becker, D. J., Sinclair, J., Castell, D. O., Wu, W. C., «A comparison of high and low fat meals on postprandial esophageal acid exposure», en Am J Gastroenterol, 84(7), 1989, pp. 782–786.

[110]. Charlton, K. E., Tapsell, L. C., Batterham, M. J., et al., «Pork, beef and chicken have similar effects on acute satiety and hormonal markers of appetite», en Appetite, 56(1), 2011, pp. 1–8.

[111]. Mitsukawa, T., Takemura, J., Ohgo, S., et al., «Gallbladder function and plasma cholecystokinin levels in diabetes mellitus», en Am J Gastroenterol, 85(8), 1990, pp. 981–985.

[112]. Matsuki, N., Fujita, T., Watanabe, N., et al., «Lifestyle factors associated with gastroesophageal reflux disease in the Japanese population», en J Gastroenterol., 48(3), 2013, pp. 340–349.

[113]. Jung, J. G., Kang, H. W., Hahn, S. J., et al., «Vegetarianism as a protective factor for reflux esophagitis: a retrospective, cross-sectional study between Buddhist priests and general population», en Dig Dis Sci., 58(8), 2013, pp. 2244–2252.

[114]. Fashner, J., Gitu, A. C., «Common gastrointestinal symptoms: risks of long-term proton pump inhibitor therapy», en FP Essent., 413, 2013, pp. 29–39.

[115]. Terry, P., Lagergren, J., Ye, W., Nyren, O., Wolk, A., «Antioxidants and cancers of the esophagus and gastric cardia», en Int J Cancer, 87(5), 2000, pp. 750–754.

[116]. Ekström, A. M., Serafini, M., Nyrén, O., Hansson, L. E., Ye, W., Wolk, A., «Dietary antioxidant intake and the risk of cardia cancer and noncardia cancer of the intestinal and diff use types: a population-based case-control study in Sweden», en Int J Cancer, 87(1), 2000, pp. 133–140.

[117]. Nilsson, M., Johnsen, R., Ye, W., Hveem, K., Lagergren, J., «Lifestyle related risk factors in the aetiology of gastro-oesophageal reflux», en Gut, 53(12), 2004, pp. 1730–1735.

[118]. Coleman, H. G., Murray, L. J., Hicks, B., et al., «Dietary fiber and the risk of precancerous lesions and cancer of the esophagus: a systematic review and meta-analysis», en Nutr Rev., 71(7), 2013, pp. 474–482.

[119]. Burkitt, D. P., «Hiatus hernia: is it preventable?» en Am J Clin Nutr., 34(3), 1981, pp. 428–431.

[120]. Burkitt, D. P., James, P. A., «Low-residue diets and hiatus hernia», en Lancet, 2(7821), 1973, pp. 128–130.

[121]. Burkitt, D. P., James, P. A., «Low-residue diets and hiatus hernia», en Lancet, 2(7821), 1973, pp. 128–130.

[122]. Burkitt, D. P., «Two blind spots in medical knowledge», en Nurs Times, 72(1), 1976, pp. 24–27.

[123]. Burkitt, D. P., «Hiatus hernia: is it preventable?», en Am J Clin Nutr., 34(3), 1981, pp. 428–431.

[124]. «American Cancer Society. Cancer Facts & Figures 2014», American Cancer Society, Atlanta, 2014.

[125]. Polednak, A. P., «Trends in survival for both histologic types of esophageal cancer in US surveillance, epidemiology and end results areas», en Int J Cancer, 105(1), 2003, pp. 98–100.

[126]. Chen, T., Yan, F., Qian, J., et al., «Randomized phase II trial of lyophilized strawberries in patients with dysplastic precancerous lesions of the esophagus», en Cancer Prev Res. (Filadelfia), 5(1), 2012, pp. 41–50.

[127]. Chen, T., Yan, F., Qian, J., et al., «Randomized phase II trial of lyophilized strawberries in patients with dysplastic precancerous lesions of the esophagus», en Cancer Prev Res. (Filadelfia), 5(1), 2012, pp. 41–50.

[128]. Eaton, S. B., Konner, M., Shostak, M., «Stone agers in the fast lane: chronic degenerative diseases in evolutionary perspective», en Am J Med., 84(4), 1988, pp. 739–749.

[129]. King, D. E., Mainous, A. G., Lambourne, C. A., «Trends in dietary fiber intake in the United States, 1999–2008», en J Acad Nutr Diet, 112(5), 2012, pp. 642–648.

[130]. Zhang, N., Huang, C., Ou, S., «In vitro binding capacities of three dietary fibers and their mixture for four toxic elements, cholesterol, and bile acid», en J Hazard Mater., 186(1), 2011, pp. 236–239.

[131]. Moshfegh, A., Goldman, J., Cleveland, l., What We Eat in America, NHANES 2001–2002: Usual Nutrient Intakes from Food Compared to Dietary Reference Intakes, US Department of Agriculture Agricultural Research Service, Washington, D. C., 2005.

 

 

5. No morir de una enfermedad infecciosa

 

[1]. «Civil Practice And Remedies Code. Title 4. Liability in Tort. Chapter 96. False Disparagement of Perishable Food Products», en la Constitución y Estatutos de Texas, <http://www.statutes.legis.state.tx.us/Docs/CP/htm/CP.96.htm>. Último acceso 3 de marzo de 2015.

[2]. «Civil Practice And Remedies Code. Title 4. Liability in Tort. Chapter 96. False Disparagement of Perishable Food Products», en la Constitución y Estatutos de Texas, <http://www.statutes.legis.state.tx.us/Docs/CP/htm/CP.96.htm>. Último acceso 3 de marzo de 2015.

[3]. Oppel Jr., R. A., «Taping of farm cruelty is becoming the crime», en New York Times, <http://www.nytimes.com/2013/04/07/us/taping-of-farm-cruelty-is-becoming-the-crime.html>, 6 de abril de 2013. Último acceso 3 de marzo de 2015.

[4]. Shrestha, S. S., Swerdlow, D. L., Borse, R. H., et al., «Estimating the burden of 2009 pandemic influenza A (H1N1) in the United States (April 2009–April 2010)», en Clin Infect Dis., 52 Suppl 1, 2011, S75–S82.

[5]. Woolhouse, M. E., Gowtage-Sequeria, S., «Host range and emerging and reemerging pathogens», en Emerging Infect Dis., 11(12), 2005, pp. 1842–1847.

[6]. Epstein, P. R., Chivian, E., Frith, K., «Emerging diseases threaten conservation», en Environ Health Perspect., 111(10), 2003, pp. A506–A507.

[7]. Espinosa de los Monteros, L. E., Galán, J. C., Gutiérrez, M., et al., «Allele-specific PCR method based on pncA and oxyR sequences for distinguishing Mycobacterium bovis from Mycobacterium tuberculosis: intraspecific M. bovis pncA sequence polymorphism», en J Clin Microbiol., 36(1), 1998, pp. 239–242.

[8]. Esmail, H., Barry, C. E., Young, D. B., Wilkinson, R. J., «The ongoing challenge of latent tuberculosis», en Philos Trans R Soc Lond, B, Biol Sci., 369(1645), 2014, p. 20130437.

[9]. Daszak, P., Cunningham, A. A., «Emerging infectious diseases: a key role for conservation medicine, en Aguirre, A. A., Ostfeld, R. S., Tabor, G. M., et al. (comps.), Conservation Medicine: Ecological Health in Practice, Oxford University Press, Oxford, 2002, pp. 40–61.

[10]. McMichael, A. J., Human Frontiers, Environments and Disease, Past Patterns, Uncertain Futures, Cambridge University Press, Cambridge, 2001.

[11]. Torrey, E. F., Yolken, R. H., Beasts of the Earth, Animals, Humans, and Disease, Rutgers University Press, New Brunswick, Nueva Jersey, 2005.

[12]. McMichael, A. J., Human Frontiers, Environments and Disease, Past Patterns, Uncertain Futures, Cambridge University Press, Cambridge, 2001.

[13]. Van Heuverswyn, F., Peeters, M., «The origins of HIV and implications for the global epidemic», en Curr Infect Dis Rep., 9(4), 2007, pp. 338–346.

[14]. Whon, T. W., Kim, M. S., Roh, S. W., Shin, N. R., Lee, H. W., Bae, J. W., «Metagenomic characterization of airborne viral DNA diversity in the near-surface atmosphere», en J Virol., 86(15), 2012, pp. 8221–8231.

[15]. USDA, «Microbiological testing of AMS purchased meat, poultry and egg commodities», en <http://www.ams.usda.gov/AMSv1.0/ams.fetchTemplateData.do?template=TemplateA&navID=MicrobialTestingofCommodities&rightNav1=MicrobialTestingofCommodities&topNav=&leftNav=&page=FPPMicroDataReports&resultType=&acct=lsstd>. Último acceso 3 de marzo de 2015.

[16]. Centers for Disease Control and Prevention, «Deaths: final data for 2013 table 10. Number of deaths from 113 selected causes», en National Vital Statistics Report, 64(2), 2016.

[17]. Barker, J., Stevens, D., Bloomfield, S. F., «Spread and prevention of some common viral infections in community facilities and domestic homes», en J Appl Microbiol., 91(1), 2001, pp. 7–21.

[18]. Boone, S. A., Gerba, C. P., «The occurrence of influenza A virus on house hold and day care center fomites», en J Infect., 51(2), 2005, pp. 103–109.

[19]. Organización Mundial de la Salud, «Directrices de la OMS sobre la higiene de manos en la atención sanitaria», en Organización Mundial de la Salud, Ginebra, <http://www.ncbi.nlm.nih.gov/books/n/whohand/pdf/>, 2009. Último acceso 4 de abril de 2015.

[20]. «How does the immune system work?», en PubMed Healt, <http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0010386/>. Último acceso 3 de marzo de 2015.

[21]. U.S. Centers for Disease Control and Prevention, «Prevention of pneumococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP)», en MMWR, 46(RR-08), 1997, pp. 1–24.

[22]. Gibson, A., Edgar, J., Neville, C., et al., «Effect of fruit and vegetable consumption on immune function in older people: a randomized controlled trial», en Am J Clin Nutr., 96(6), 2012, pp. 1429–1436.

[23]. USDA, «Food availability (per capita) Data System. Fresh kale: per capita availability adjusted for loss», en <http://www.ers.usda.gov/datafiles/FoodAvailabilyPerCapitaDataSystem/LossAdjustedFoodAvailability/veg.xls>. Último acceso 3 de marzo de 2015.

[24]. Nishi, K., Kondo, A., Okamoto, T., et al., «Immunostimulatory in vitro and in vivo effects of a water-soluble extract from kale», en Biosci Biotechnol Biochem., 75(1), 2011, pp. 40–46.

[25]. Nishi, K., Kondo, A., Okamoto, T., et al., «Immunostimulatory in vitro and in vivo effects of a water-soluble extract from kale», en Biosci Biotechnol Biochem., 75(1), 2011, pp. 40–46.

[26]. Macdonald, T. T., Monteleone, G., «Immunity, inflammation, and allergy in the gut», en Science, 307(5717), 2005, pp. 1920–1925.

[27]. United States Census Bureau, «Median and average square feet of floor area in new single-family houses completed by location», en <https://www.census.gov/const/C25Ann/sftotalmedavgsqft.pdf>. Último acceso 3 de abril de 2015.

[28]. Sheridan, B. S., Lefrançois, L., «Intraepithelial lymphocytes: To serve and protect», en Curr Gastroenterol Rep., 12(6), 2010, pp. 513–521.

[29]. Hooper, L. V., «You AhR what you eat: linking diet and immunity», en Cell, 147(3), 2011, pp. 489–491.

[30]. Esser, C., «Biology and function of the aryl hydrocarbon receptor: report of an international and interdisciplinary conference», en Arch Toxicol., 86(8), 2012, pp. 1323–1329.

[31]. Veldhoen, M., «Direct interactions between intestinal immune cells and the diet», en Cell Cycle, 11(3), 1 de febrero de 2012, pp. 426–427.

[32]. Hooper, L. V., «You AhR what you eat: linking diet and immunity», en Cell, 147(3), 2011, pp. 489–491.

[33]. Savouret, J. F., Berdeaux, A., Casper, R. F., «The aryl hydrocarbon receptor and its xenobiotic ligands: A fundamental trigger for cardiovascular diseases», en Nutr Metab Cardiovasc Dis., 13(2), 2003, pp. 104–113.

[34]. Ashida, H., Fukuda, I., Yamashita, T., Kanazawa, K., «Flavones and flavonols at dietary levels inhibit a transformation of aryl hydrocarbon receptor induced by dioxin», en FEBS Lett., 476 (3), 2000, pp. 213–217.

[35]. Ashida, H., Fukuda, I., Yamashita, T., Kanazawa, K., «Flavones and flavonols at dietary levels inhibit a transformation of aryl hydrocarbon receptor induced by dioxin», en FEBS Lett., 476 (3), 2000, pp. 213–217.

[36]. Alhaider, A. A., El-Gendy, M. A. M., Korashy, H. M., El-Kadi A. O. S., «Camel urine inhibits the cytochrome P450 1a1 gene expression through an AhR-dependent mechanism in Hepa 1c1c7 cell line», en J Ethnopharmacol., 133(1), 2011, pp. 184–190.

[37]. Watts, A. R., Lennard, M. S., Mason, S. L., Tucker, G. T., Woods, H. F., «Beeturia and the biological fate of beetroot pigments», en Pharmacogenetics, 3(6), 1993, pp. 302–311.

[38]. Yalindag-Ozturk, N., Ozdamar, M., Cengiz, P., «Trial of garlic as an adjunct therapy for multidrug resistant Pseudomonas aeruginosa pneumonia in a critically ill infant», en J Altern Complement Med., 17(4), 2011, pp. 379–380. EPUB 11 de abril de 2011.

[39]. Seeram, N. P., «Recent trends and advances in berry health benefits research», en J Agric Food Chem., 58(7), 2010, pp. 3869–3870.

[40]. Seeram, N. P., «Berry fruits for cancer prevention: Current status and future prospects», en J Agric Food Chem., 56(3), 2008, pp. 630–635.

[41]. Caligiuri, M. A., «Human natural killer cells», en Blood, 112(3), 2008, pp. 461–469.

[42]. McAnulty, L. S., Nieman, D. C, Dumke, C. L., et al., «Effect of blueberry ingestion on natural killer cell counts, oxidative stress, and inflammation prior to and after 2.5 H of running», en Appl Physiol Nutr Metab., 36(6), 2011, pp. 976–984.

[43]. Majdalawieh, A. F., Carr, R. I., «In vitro investigation of the potential immunomodulatory and anticancer activities of black pepper (Piper nigrum) and cardamom (Elettaria cardamomum)», en J Med Food, 13(2), 2010, pp. 371–381.

[44]. Bager, P., Wohlfahrt, J., Westergaard, T., «Caesarean delivery and risk of atopy and allergic disease: Meta-analyses», en Clin Exp Allergy, 38(4), 2008, pp. 634–642.

[45]. Benn, C. S., Thorsen, P., Jensen, J. S., et al., «Maternal vaginal microflora during pregnancy and the risk of asthma hospitalization and use of antiasthma medication in early childhood», en J Allergy Clin Immunol., 110(1), 2002, pp. 72–77.

[46]. Sheih, Y. H., Chiang, B. L., Wang, L. H, Liao, C. K., Gill, H. S., «Systemic immunity-enhancing effects in healthy subjects following dietary consumption of the lactic acid bacterium Lactobacillus rhamnosus HN001», en J Am Coll Nutr., 20(Suppl 2), 2001, pp. 149–156.

[47]. Berggren, A., Lazou Ahrhiang, B. L., Wang, L. H., Liao, G., «Randomised, double-blind and placebo-controlled study using new probiotic lactobacilli for strengthening the body immune defence against viral infections», en Eur J Nutr., 50(3), 2011, pp. 203–210.

[48]. Hao, Q., Lu, Z., Dong, B. R., Huang, C. Q., Wu, T., «Probiotics for preventing acute upper respiratory tract infections», en Cochrane Database Syst Rev., 9, 2011, pp. 1–42

[49]. Homayoni Rad, A., Akbarzadeh, F., Mehrabany, E. V., «Which are more important: prebiotics or probiotics?», en Nutrition, 28(11–12), 2012, pp. 1196–1197.

[50]. Vitali, B., Minervini, G., Rizzello, C. G., et al., «Novel probiotic candidates for humans isolated from raw fruits and vegetables», en Food Microbiol., 31(1), 2012, pp. 116–125.

[51]. Nieman, D. C., «Moderate exercise improves immunity and decreases illness rates», en Am J Lifestyle Med., 5(4), 2011, pp. 338–345.

[52]. Schwindt, C. D., Zaldivar, F., Wilson, L., et al., «Do circulating leucocytes and lymphocyte subtypes increase in response to brief exercise in children with and without asthma?», en Br J Sports Med., 41(1), 2007, pp. 34–40.

[53]. Nieman, D. C., Henson, D. A., Gusewitch, G., et al., «Physical activity and immune function in elderly women», en Med Sci Sports Exerc., 25(7), 1993, pp. 823–831.

[54]. Neville, V., Gleeson, M., Folland, J. P., «Salivary IgA as a risk factor for upper respiratory infections in elite professional athletes», en Med Sci Sports Exerc., 40(7), 2008, pp. 1228–1236.

[55]. Otsuki, T., Shimizu, K., Iemitsu, M., Kono, I., «Salivary secretory immunoglobulin A secretion increases after 4-weeks ingestion of chlorella-derived multicomponent supplement in humans: a randomized cross over study», en Nutr J., 10, 9 de septiembre de 2011, p. 91.

[56]. Klentrou, P., Cieslak, T., MacNeil, M., Vintinner, A., Plyley, M., «Effect of moderate exercise on salivary immunoglobulin A and infection risk in humans», en Eur J Appl Physiol., 87(2), 2002, pp. 153–158.

[57]. Nieman, D. C., «Moderate exercise improves immunity and decreases illness rates», en Am J Lifestyle Med., 5(4), 2011, pp. 338–346.

[58]. Walsh, N. P., Gleeson, M., Shephard, R. J., et al., «Position statement. Part one: immune function and exercise», en Exerc Immunol Rev., 17, 2011, pp. 6–63.

[59]. Akimoto, T., Nakahori, C., Aizawa, K., Kimura, F., Fukubayashi, T., Kono, I., «Acupuncture and responses of immunologic and endocrine markers during competition», en Med Sci Sports Exerc., 35(8), 2003, pp. 1296–1302.

[60]. Neville, V., Gleeson, M., Folland, J. P., «Salivary IgA as a risk factor for upper respiratory infections in elite professional athletes», en Med Sci Sports Exerc., 40(7), 2008, pp. 1228–1236.

[61]. Nieman, D. C., «Exercise effects on systemic immunity», en Immunol Cell Biol., 78(5), 2000, pp. 496–501.

[62]. Otsuki, T., Shimizu, K., Iemitsu, M., Kono, I., «Salivary secretory immunoglobulin A secretion increases after 4-weeks ingestion of chlorella-derived multicomponent supplement in humans: a randomized cross over study», en Nutr J., 10, 9 de septiembre de 2011, p. 91.

[63]. Halperin, S. A., Smith, B., Nolan, C., Shay, J., Kralovec, J., «Safety and immunoenhancing effect of a Chlorella-derived dietary supplement in healthy adults undergoing influenza vaccination: randomized, double-blind, placebo-controlled trial», en CMAJ, 169(2), 22 de julio de 2003, pp. 111–117.

[64]. Otsuki, T., Shimizu, K., Iemitsu, M., Kono, I., «Chlorella intake attenuates reduced salivary SIgA secretion in kendo training camp participants», en Nutr J., 11, 11 de diciembre de 2012, pp. 103.

[65]. Selvaraj, V., Singh, H., Ramaswamy, S., «Chlorella-induced psychosis», en Psychosomatics, 54(3), 2013, pp. 303–304.

[66]. Selvaraj, V., Singh, H., Ramaswamy, S., «Chlorella-induced psychosis», en Psychosomatics, 54(3), 2013, pp. 303–304.

[67]. Carpenter, K. C., Breslin, W. L., Davidson, T., Adams, A., McFarlin, B. K., «Baker’s yeast ß-glucan supplementation increases monocytes and cytokines post-exercise: implications for infection risk?», en Br J Nutr., 109(3), 2013, pp. 478–486.

[68]. Carpenter, K. C., Breslin, W. L., Davidson, T., Adams, A., McFarlin, B. K., «Baker’s yeast ß-glucan supplementation increases monocytes and cytokines post-exercise: implications for infection risk?», en Br J Nutr., 109(3), 2013, pp. 478–486.

[69]. Talbott, S., Talbott, J., «Effect of BETA 1, 3/1, 6 GLUCAN on upper respiratory tract infection symptoms and mood state in marathon athletes», en J Sports Sci Med., 8(4), 1 de diciembre de 2009, pp. 509–515.

[70]. Merrill, R. M., Isakson, R. T., Beck, R. E., «The association between allergies and cancer: what is currently known?», en Ann Allergy Asthma Immunol., 99(2), 2007, pp. 102–116.

[71]. Wakchaure, G. C., «Production and marketing of mushrooms: global and national scenario», en Singh, M., (comp.), Mushrooms: Cultivation, Marketing and Consumption, Indian Council of Agricultural Research Directorate of Mushroom Research, 2011.

[72]. Jeong, S. C., Koyyalamudi, S. R., Pang, G., «Dietary intake of Agaricus bisporus white button mushroom accelerates salivary immunoglobulin A secretion in healthy volunteers», en Nutrition, 28(5), 2012, pp. 527–531.

[73]. Jeong, S. C., Koyyalamudi, S. R., Pang, G., «Dietary intake of Agaricusbisporus white button mushroom accelerates salivary immunoglobulin A secretion in healthy volunteers», en Nutrition, 28(5), 2012, pp. 527–531.

[74]. Moro, C., Palacios, I., Lozano, M., et al., «Anti-inflammatory activity of methanolic extracts from edible mushrooms in LPS activated RAW 264. 7 macrophages», en Food Chemistry, 130, 2012, pp. 350–355.

[75]. Jesenak, M., Hrubisko, M., Majtan, J., Rennerova, Z., Banovcin, P., «Anti-allergic effect of Pleuran (ß-glucan from Pleurotus ostreatus) in children with recurrent respiratory tract infections», en Phytother Res., 28(3), 2014, pp. 471–474.

[76]. Centers for Disease Control and Prevention, «Estimates of foodborne illness in the United States», en <http://www.cdc.gov/foodborneburden/>. Último acceso 3 de marzo de 2015.

[77]. Batz, M. B., Hoffmann, S., Morris Jr., J. G., «Ranking the disease burden of 14 pathogens in food sources in the United States using attribution data from outbreak investigations and expert elicitation», en J Food Prot., 75(7), 2012, pp. 1278–1291.

[78]. Park, S., Navratil, S., Gregory, A., et al., «Multifactorial effects of ambient temperature, precipitation, farm management, and environmental factors determine the level of generic Escherichia coli contamination on preharvested spinach», en Appl Environ Microbiol., 81(7), 2015, pp. 2635–2650.

[79]. Hoffmann, S., Batz, M. B., Morris Jr., J. G., «Annual cost of illness and quality-adjusted life year losses in the United States due to 14 foodborne pathogens», en J Food Prot., 75(7), 2012, pp. 1292–1302.

[80]. Chai, S. J., White, P. L., «Salmonella enterica Serotype Enteritidis: increasing incidence of domestically acquired infections», en Clin Infect Dis., 54(Sup5), 2012, pp. 488–497.

[81]. «Salmonella», en Centers for Disease Control and Prevention, <http://www.cdc.gov/salmonella/>. Último acceso 3 de marzo de 2015.

[82]. Baura, G. D., «The incredible inedible egg», en IEEE Pulse, 1(3) noviembre-diciembre de 2010, pp. 56–62.

[83]. Krouse, B., «Opposing view on food safety: committed to safety», en USA Today, <http://usatoday30.usatoday.com/news/opinion/editorials/2010-08-30-edi torial30ST1N.htm>. Último acceso 3 de marzo de 2015.

[84]. Davis, A. L., Curtis, P. A., Conner, D. E., McKee, S. R., Kerth, L. K., «Validation of cooking methods using shell eggs inoculated with Salmonella serotypes Enteritidis and Heidelberg», en Poult Sci., 87(8), 2008, pp. 1637–1642.

[85]. Stadelman, W. J., Muriana, P. M., Schmieder, H., «The effectiveness of traditional egg-cooking practices for elimination of Salmonella enteritidis», en Poult Sci., 74(s1), 1995, p. 119.

[86]. Humphrey, T. J., Greenwood, M., Gilbert, R. J., Rowe, B., Chapman, P. A., «The survival of salmonellas in shell eggs cooked under simulated domestic conditions», en Epidemiol Infect., 103, 1989, pp. 35–45.

[87]. U.S. Food and Drug Administration, «Playing it safe with eggs», en <http://www.fda.gov/food/resourcesforyou/Consumers/ucm077342.htm>. Último acceso 3 de marzo de 2015.

[88]. Batz, M. B., Hoffmann. S., Morris Jr., J. G., «Ranking the disease burden of 14 pathogens in food sources in the United States using attribution data from outbreak investigations and expert elicitation», en J Food Prot., 75(7), 2012, pp. 1278–1291.

[89]. Centers for Disease Control and Prevention, «Multistate outbreak of multidrug-resistant Salmonella Heidelberg infections linked to Foster Farms brand chicken», en <http://www.cdc.gov/salmonella/heidelberg-10-13/>. Último acceso 3 de marzo de 2015.

[90]. USDA, «Notice of Intended Enforcement», en <http://www.marlerblog.com/files/2013/10/foster-farms-est-6137a-p1.pdf>. Último acceso 3 de marzo de 2015.

[91]. Voetsch, A. C., Van Gilder, T. J., Angulo, F. J., et al., «FoodNet estimate of the burden of illness caused by nontyphoidal Salmonella infections in the United States», en Clin Infect Dis., 38(Supplement-3), 2004, pp. S127–S134.

[92]. USDA, «Notice of Intended Enforcement», en <http://www.marlerblog.com/files/2013/10/foster-farms-est-6137a-p1.pdf>. Último acceso 3 de marzo de 2015.

[93]. Pierson, D., «Mexico blocks Foster Farms chicken imports amid salmonella fears», en LA Times, <http://articles.latimes.com/2013/oct/24/business/la-fi-foster-farms-mexico-20131025>. Último acceso 3 de marzo de 2015.

[94]. Supreme Beef Processors, Inc. vs. United States Dept. of Agriculture, 275 F. 3d 432 (5th Cir 2001).

[95]. Fravalo, P., Laisney, M. J., Gillard, M. O., Salvat, G., Chemaly, M., «Campylobacter transfer from naturally contaminated chicken thighs to cutting boards is inversely related to initial load», en J Food Prot., 72(9), 2009, pp. 1836–1840.

[96]. Guyard-Nicodème, M., Tresse, O., Houard, E., et al., «Characterization of Campylobacter spp. transferred from naturally contaminated chicken legs to cooked chicken slices via a cutting board», en Int J Food Microbiol., 164(1), 3 de junio de 2013, pp. 7–14.

[97]. «Foster Farms Provides Food Safety Update», en Close Up Media Website, <http://closeupmedia.com/food/Foster-Farms-Provides-Food-Safety-Update.html>, 2013. Último acceso 5 de marzo de 2015.

[98]. Hoffmann, S., Batz, M. B., Morris Jr., J. G., «Annual cost of illness and quality-adjusted life year losses in the United States due to 14 foodborne pathogens», en J Food Prot., 75(7), 2012, pp. 1292–1302.

[99]. Karapetian, A., «Model EU», en Meatingplace, marzo de 2015, p. 91.

[100]. «The high cost of cheap chicken», en Consumer Reports, <http://www.consumerreports.org/cro/magazine/2014/02/the-high-cost-of-cheap-chicken/index.htm>, febrero de 2014. Último acceso 5 de marzo de 2015.

[101]. Centers for Disease Control and Prevention, «Antibiotic Resistance Threats in the United States, 2013», en <http://www.cdc.gov/drugresistance/threat-report-2013/pdf/ar-threats-2013-508.pdf>. Último acceso 3 de marzo de 2015.

[102]. «Mayo Clinic Staff. Salmonella infection», en The Mayo Clinic, <http://www.mayoclinic.org/diseases-conditions/salmonella/basics/causes/con-20029017>. Último acceso 3 de marzo de 2015.

[103]. U.S. Food and Drug Administration, «NARMS 2011 retail meat annual report», en <http://www.fda.gov/downloads/AnimalVeterinary/SafetyHealth/AntimicrobialResistance/NationalAntimicrobialResistanceMonitoringSystem/UCM334834.pdf>. Último acceso 3 de abril de 2015.

[104]. U.S. Food and Drug Administration, «NARMS 2011 retail meat annual report», en <http://www.fda.gov/downloads/AnimalVeterinary/SafetyHealth/An timicrobialResistance/NationalAntimicrobialResistanceMonitoringSystem/UCM334834.pdf>. Último acceso 3 de abril de 2015.

[105]. NA, «Vital signs: incidence and trends of infection with pathogens transmitted commonly through food—foodborne diseases active surveillance network, 10 U.S. Sites, 1996–2010», en MMWR Morb Mortal Wkly Rep., 60(22), 2011, pp. 749–755.

[106]. Chai, S. J., White, P. L., Lathrop, S. L., et al., «Salmonella enterica serotype Enteritidis: increasing incidence of domestically acquired infections», en Clin Infect Dis., 54-Suppl-5(NA), 2012, pp. S488–S497.

[107]. Hoffmann, S., Batz, M. B., Morris Jr., J. G., «Annual cost of illness and quality-adjusted life year losses in the United States due to 14 foodborne pathogens», en J Food Prot., 75(7), 2012, pp. 1292–1302.

[108]. «511 F. 2d 331-American Public Health Association v. Butz», en <http://openjurist.org/511/f2d/331/american-public-health–association-v-butz>. Último acceso 3 de marzo de 2015.

[109]. «Supreme Beef Processors v. U.S. Dept. of Agriculture», en United States Court of Appeals, Fifth Circuit, <http://www.leagle.com/decision/2001707275 F3d432_1672>. Último acceso 3 de marzo de 2015.

[110]. Stamey, T. A., Timothy, M., Millar, M., Mihara, G., «Recurrent urinary infections in adult women. The role of introital enterobacteria», en Calif Med., 115(1), 1971, pp. 1–19.

[111]. Yamamoto, S., Tsukamoto, T., Terai, A., Kurazono, H., Takeda, Y., Yoshida, O., «Genetic evidence supporting the fecal-perineal-urethral hypothesis in cystitis caused by Escherichia coli», en J Urol., 157(3), 1997, pp. 1127–1129.

[112]. Bergeron, C. R., Prussing, C., Boerlin, P., et al., «Chicken as reservoir for extraintestinal pathogenic Escherichia coli in humans, Canada», en Emerging Infect Dis., 18(3), 2012, pp. 415–421.

[113]. Jakobsen, L., Garneau, P., Bruant, G., et al., «Is Escherichia coli urinary tract infection a zoonosis? Proof of direct link with production animals and meat», en Eur J Clin Microbiol Infect Dis., 31(6), 2012, pp. 1121–1129.

[114]. Foxman, B., Barlow, R., D’arcy, H., Gillespie, B., Sobel, J. D., «Urinary tract infection: self-reported incidence and associated costs», en Ann Epidemiol., 10(8), 2000, pp. 509–515.

[115]. Platell, J. L., Johnson, J. R., Cobbold, R. N., Trott, D. J., «Multidrug-resistant extraintestinal pathogenic Escherichia coli of sequence type ST131 in animals and foods», en Vet Microbiol., 153(1–2), 2011, pp. 99–108.

[116]. Linton, A. H., Howe, K., Bennett, P. M., Richmond, M. H., Whiteside, E. J., «The colonization of the human gut by antibiotic resistant Escherichia coli from chickens», en J Appl Bacteriol., 43(3), 1977, pp. 465–469.

[117]. Linton, A. H., Howe, K., Bennett, P. M., Richmond, M. H., Whiteside, E. J., «The colonization of the human gut by antibiotic resistant Escherichia coli from chickens», en J Appl Bacteriol., 43(3), 1977, pp. 465–469.

[118]. Rusin, P., Orosz-Coughlin, P., Gerba, C., «Reduction of faecal coliform, coliform and heterotrophic plate count bacteria in the house hold kitchen and bathroom by disinfection with hypochlorite cleaners», en J Appl Microbiol., 85(5), 1998, pp. 819–828.

[119]. Cogan, T. A., Bloomfield, S. F., Humphrey, T. J., «The effectiveness of hygiene procedures for prevention of cross-contamination from chicken carcases in the domestic kitchen», en Lett Appl Microbiol., 29(5), 199, pp. 354–358.

[120]. Cogan, T. A., Bloomfield, S. F., Humphrey, T. J., «The effectiveness of hygiene procedures for prevention of cross-contamination from chicken carcases in the domestic kitchen», en Lett Appl Microbiol., 29(5), 199, pp. 354–358.

[121]. Cogan, T. A., Bloomfield, S. F., Humphrey, T. J., «The effectiveness of hygiene procedures for prevention of cross-contamination from chicken carcases in the domestic kitchen», en Lett Appl Microbiol., 29(5), 199, pp. 354–358.

[122]. Linton, A. H., Howe, K., Bennett, P. M., Richmond, M. H., Whiteside, E. J., «The colonization of the human gut by antibiotic resistant Escherichia coli from chickens», en J Appl Bacteriol., 43(3), 1977, pp. 465–469

[123]. Scallan, E., Hoekstra, R. M., Angulo, F. J., et al., «Foodborne illness acquired in the United States—major pathogens», en Emerging Infect Dis., 17, 2011, pp. 7–15.

[124]. Batz, M. B., Hoffmann. S., Morris Jr., J. G., «Ranking the disease burden of 14 pathogens in food sources in the United States using attribution data from outbreak investigations and expert elicitation», en J Food Prot., 75(7), 2012, pp. 1278–1291.

[125]. Zheng, H., Sun, Y., Lin, S., Mao, Z., Jiang, B., «Yersinia enterocolitica infection in diarrheal patients», en Eur J Clin Microbiol Infect Dis., 27, 2008, pp. 741–752.

[126]. Bari, M. L., Hossain, M. A., Isshiki, K., Ukuku, D., «Behavior of Yersinia enterocolitica in foods», en J Pathog., 2011, 2011, p. 420732.

[127]. Ternhag, A., Törner, A., Svensson, A., Ekdahl, K., Giesecke, J., «Short and long-term effects of bacterial gastrointestinal infections», en Emerging Infect Dis., 14, 2008, pp. 143–148.

[128]. Brix, T. H., Hansen, P. S., Hegedüs, L., Wenzel, B. E., «Too early to dismiss Yersinia enterocolitica infection in the aetiology of Graves’ disease: evidence from a twin case-control study», en Clin Endocrinol (Oxford)., 69, 2008, pp. 491–496.

[129]. «What’s in that pork?», en Consumer Reports, <http://www.consumerreports.org/cro/magazine/2013/01/what-s-in-that-pork/index.htm>. Último acceso 3 de marzo de 2015.

[130]. Bari, M. L., Hossain, M. A., Isshiki, K., Ukuku, D., «Behavior of Yersinia enterocolitica in foods», en J Pathog., 2011, 2011, p. 420732.

[131]. «Crowding pigs pays—if it’s managed properly», en National Hog Farmer, 62, 15 de noviembre de 1993.

[132]. Poljak, Z., Dewey, C. E., Martin, S. W., et al., «Prevalence of Yersinia enterocolitica shedding and bioserotype distribution in Ontario finisher pig herds in 2001, 2002, and 2004», en Prev Vet Med., 93, 2010, pp. 110–120.

[133]. Hoffmann, S., Batz, M. B., Morris Jr., J. G., «Annual cost of illness and quality-adjusted life year losses in the United States due to 14 foodborne pathogens», en J Food Prot., 75(7), 2012, pp. 1292–1302.

[134]. Centers for Disease Control and Prevention, «Antibiotic Resistance Threats in the United States, 2013», en <http://www.cdc.gov/drugresistance/threat-report-2013/pdf/ar-threats-2013-508.pdf>. Último acceso 3 de marzo de 2015.

[135]. Eyre, D. W., Cule, M. L., Wilson, D. J., et al., «Diverse sources of C. difficile infection identified on whole-genome sequencin», en N Engl J Med., 369(13), 26 de septiembre de 2013, pp. 1195–1205.

[136]. Songer, J. G., Trinh, H. T., Killgore, G. E., Thompson, A. D., McDonald, L. C., Limbago, B. M., «Clostridium difficile in retail meat products, USA, 2007», en Emerg Infect Dis., 15(5), 2009, pp. 819–821.

[137]. Rupnik, M., Songer, J. G., «Clostridium difficile: its potential as a source of foodborne disease», en Adv Food Nutr Res., 60, 2010, pp. 53–66.

[138]. Rodriguez-Palacios, A., Borgmann, S., Kline, T. R., LeJeune, J. T., «Clostridium difficile in foods and animals: history and measures to reduce exposure», en Anim Health Res Rev., 14(1), 2013, pp. 11–29.

[139]. Hensgrens, M. P. M., Keessen, E. C., Squire, M. M., et al., «European Society of Clinical Microbiology and Infectious Diseases Study Group for Clostridium difficile (ESGCD). Clostridium difficile infection in the community: a zoonotic disease?», en Clin Microbiol Infect., 18(7), 2012, pp. 635–645.

[140]. Rupnik, M., Songer, J. G., «Clostridium difficile: its potential as a source of foodborne disease», en Adv Food Nutr Res., 60, 2010, pp. 53–66.

[141]. Sayedy, L., Kothari, D., Richards, R. J., «Toxic megacolon associated Clostridium difficile colitis», en World J Gastrointest Endosc., 2(8), 2010, pp. 293–297.

[142]. Gweon, T. G., Lee, K. J., Kang, D. H., et al., «A case of toxic megacolon caused by Clostridium difficile infection and treated with fecal microbiota transplantation», en Gut Liver, 9(2), 2015, pp. 247–250.

[143]. Weese, J. S., «Clostridium difficile in food—innocent bystander or serious threat?», en Clin Microbiol Infect., 16, 2010, pp. 3–10.

[144]. Jabbar, U., Leischner, J., Kasper, D., et al., «Effectiveness of alcohol-based hand rubs for removal of Clostridium difficile spores from hands», en Infect Control Hosp Epidemiol., 31(6), 2010, pp. 565–570.

[145]. Bhargava, K., Wang, X., Donabedian, S., Zervos, M., de Rocha, L., Zhang, Y., «Methicillin-resistant Staphylococcus aureus in retail meat, Detroit, Michigan, USA», en Emerging Infect Dis., 17(6), 2011, pp. 1135–1357.

[146]. Reinberg, S., «Scientists find MRSA germ in supermarket meats», en <http://usatoday30.usatoday.com/news/health/medical/health/medical/story/2011/05/Scientists-find-MRSA-germ-in-supermarket-meats/47105974/1>, 12 de mayo de 2012. Último acceso 4 de abril de 2015.

[147]. Chan, M., «Antimicrobial resistance in the European Union and the world», en Conference on combating antimicrobial resistance: time for action, Copenhagen, Dinamarca, 14 de marzo de 2012. <http://www.who.int/dg/speeches/ 2012/amr_20120314/en/>. Último acceso 6 de marzo de 2015.

[148]. Love, D. C., Halden, R. U., Davis, M. F., Nachman, K. E., «Feather meal: a previously unrecognized route for reentry into the food supply of multiple pharmaceuticals and personal care products (PPCPs)», en Environ Sci Technol., 46(7), 2012, pp. 3795–3802.

[149]. Ji, K., Kho, Y., Park, C., et al., «Influence of water and food consumption on inadvertent antibiotics intake among general population», en Environ Res., 110(7), 2010, pp. 641–649.

[150]. Ji, K., Lim Kho, Y. L., Park, Y., Choi, K., «Influence of a five-day vegetarian diet on urinary levels of antibiotics and phthalate metabolites: a pi lot study with “Temple Stay” participants», en Environ Res., 110(4), 2010, pp. 375–382.

[151]. «Keep Antibiotics Working», en <http://www.keepantibioticsworking.com/new/indepth_groups.php>. Último acceso 3 de marzo de 2015.

[152]. Hayes, D. J., Jenson, H. H., «Technology choice and the economic effects of a ban on the use of antimicrobial feed additives in swine rations», en Food Control, 13(2), 2002, pp. 97–101.

[153]. «Rival diet doc leaks Atkins death report», en <http://www.thesmoking gun.com/file/rival-dietdoc-leaks-atkins-death-report?page=3>. Último acceso 3 de marzo de 2015.

[154]. «Corporate Threat», en <http://www.atkinsexposed.org/Corporate_Threat.htm>. Último acceso 14 de junio de 2015.